Gujarat Technological University Student list for M.Pharm Sem 3 (Regular) Dissertation Phase-1 Exam (Winter 2019) GTU/W19/DP-1/MPH-3213/12167 Date:- 11/11/2019

Branch_C College_ Branch_T Guide Sr. No. Date MAP_NUMBER Student_name sub code Branch_name Micro Other_Micro DP1_TITLE Guide Name ode Code ype Code BUCO/MUCOADHESIVE, PANCHAL KUNAL PRAKASHCHANDRA (NON FORMULATION AND EVALUATION OF SUSTAINED RELEASE 1 19-Nov-19 182060820002 MRW304P 20 206 MP Pharmaceutics TDDS, TOPICAL, DR.MITTAL MAHESHWARI 206 PGCET) BUCCAL TABLETS OF ZOLPIDEM TARTRATE HYDROGELS NASAL BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF GASTRORETENTIVE 2 19-Nov-19 182060820004 Vekariya pareshkumar jagdishbhai MRW304P 20 206 MP Pharmaceutics TDDS, TOPICAL, MUCOADHESIVE TABLETS OF KETOROLAC DR. MITTAL MAHESHWARI 206 HYDROGELS NASAL TROMETHAMINE ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION 3 19-Nov-19 182060824002 Patel Nidhi Shaileshbhai MRW304P 24 206 MP Quality STABILITY STUDIES DR.NEHA TIWARI 206 OF DAPAGLIFLOZIN, SAXAGLIPTIN AND METFORMIN Assurance HYDROCHLORIDE IN SYNTHETIC MIXTURE. Pharmaceutical STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT 4 19-Nov-19 182060824007 SHAH PRIYA MANISHKUMAR MRW304P 24 206 MP Quality STABILITY STUDIES AND VALIDATION FOR FERRIC MALTOL AND IT’S DR. PRAGNESH PATANI 206 Assurance PHARMACEUTICAL DOSAGE FORM Pharmaceutical STABILITY INDICATING HPLC METHOD DEVELOPEMENT 5 19-Nov-19 182060824005 PRAJAPATI RAHUL CHINTAMANI (PGCET) MRW304P 24 206 MP Quality STABILITY STUDIES AND VALIDATION FOR THE ESTIMATION OF PEXIDARTINIB DR. NEHA TIWARI 206 Assurance IN PHARMACEUTICAL DOSAGE FORM

Pharmaceutical QUANTITATIVE ESTIMATION OF API IN SOME COMMONLY QUANTITATIVE 6 19-Nov-19 182060824008 SIYOLA DHRUVI CHIMANBHAI (PGCET) MRW304P 24 206 MP Quality OTHER (KINDLY SPECIFY) USED BRANDED AND GENERIC ANTI HYPERLIPIDEMIC DR.PRAGNESH PATANI 206 ESTIMATION Assurance DRUG USING VARIOUS SPECTROSCOPIC TECHNIQUES.

Pharmaceutical QUANTITATIVE ESTIMATION OF API IN SOME COMMONLY QUANTITATIVE 7 19-Nov-19 182060824001 CHAUHAN JAYNISH NAVNITBHAI MRW304P 24 206 MP Quality OTHER (KINDLY SPECIFY) USED BRANDED AND GENERIC ANTIDIABETIC DRUGS DR. PRAGNESH PATANI 206 ESTIMATION Assurance USING VARIOUS SPECTROSCOPIC TECHNIQUES

Pharmaceutical QUANTITATIVE ESTIMATION OF API IN SOME COMMONLY PRAJAPATI ABHISHEK NARESHBHAI (NON QUANTITATIVE 8 19-Nov-19 182060824004 MRW304P 24 206 MP Quality OTHER (KINDLY SPECIFY) USED BRANDED AND GENERIC ANTIHYPERTENSIVE DRUGS DR. PRAGNESH PATANI 206 PGCET) ESTIMATION Assurance USING VARIOUS SPECTROSCOPIC TECHNIQUES IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF ACETAMINOPHEN 9 19-Nov-19 182080820003 PANDYA ARTH JAYESH MRW304P 20 208 MP Pharmaceutics FAST DR. DASHARATH M. PATEL 208 MOUTH DISSOLVING TABLET. DISPERSIBLE/DISSOLVI DELAYED/EXTENDED FORMULATION AND EVALUATION OF COMPRESSION- 10 19-Nov-19 182080820004 PANDYA SHIVANI SHAILESHBHAI MRW304P 20 208 MP Pharmaceutics RELEASE, FLOATING, COATED PULSATILE RELEASE TABLET OF ETODOLAC FOR DR. UPENDRA L. PATEL 208 INSITU RHEUMATOID ARTHRITIS. DELAYED/EXTENDED FORMULATION AND EVALUATION OF IMMEDIATE RELEASE 11 19-Nov-19 182080820005 PATEL AKASH BHAVDEEPBHAI MRW304P 20 208 MP Pharmaceutics RELEASE, FLOATING, MR. BHAVIN BHIMANI 208 OF SILDENAFIL AND SUSTAINED RELEASE OF FLUOXETINE. INSITU DELAYED/EXTENDED FORMULATION AND EVALUATION OF MICROSPHERES 12 19-Nov-19 182080820008 PATEL HIRANGI KIRTIKUMAR MRW304P 20 208 MP Pharmaceutics RELEASE, FLOATING, DR. HIRAL SHAH 208 BASED TOPICAL GEL OF APREMILAST. INSITU FORMULATION AND EVALUATION OF MEDICATED 13 19-Nov-19 182080820001 BHATT KAUSHIKKUMAR JAYANTKUMAR MRW304P 20 208 MP Pharmaceutics OTHER (KINDLY SPECIFY) LOZENGES MR. GHANSHYAM PATEL 208 LOZENGES OF TRIAMCINOLONE ACETONIDE. VESICULAR DRUG NANOEMULSION BASED NOSE TO BRAIN DELIVERY OF 14 19-Nov-19 182080820006 PATEL DHWANIBAHEN ARVINDBHAI MRW304P 20 208 MP Pharmaceutics DR. SUNITA CHAUDHARY 208 DELIVERY SYSTEM DOLUTEGRAVIR. PREPARATION AND CHARACTERIZATION OF VESICULAR DRUG 15 19-Nov-19 182080820007 PATEL DRASHTI INDRAVADANBHAI MRW304P 20 208 MP Pharmaceutics DEXIBUPROFEN SUSPENSION FOR INTRAMUSCULAR DR. UPENDRA L. PATEL 208 DELIVERY SYSTEM DEPOT THERAPY. FORMULATION AND EVALUATION OF TASTE MASKED DRY 16 19-Nov-19 182080820009 SHARMA ASHUTOSH MUNESHCHANDRA MRW304P 20 208 MP Pharmaceutics OTHER (KINDLY SPECIFY) TEST MASKING DR. DASHARATH M. PATEL 208 SYRUP OF CEFUROXIME AXETIL. DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING HPTLC METHOD FOR SIMULTANEOUS 17 19-Nov-19 182080824002 KOTHARI DHRUV HARIKRUSHNBHAI MRW304P 24 208 MP Quality STABILITY STUDIES DR JIGNASHA DERASARI 208 ESTIMATION OF AMLODIPINE BESYLATE AND CELECOXIB IN Assurance PHARMACEUTICAL DOSAGE FORM

Page 1 Pharmaceutical STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT 18 19-Nov-19 182080824006 PATEL NIDHI DINESHKUMAR MRW304P 24 208 MP Quality STABILITY STUDIES AND VALIDATION OF FEBUXOSTAT IN TABLET DOSAGE MR. HIREN KADIKAR 208 Assurance FORM Pharmaceutical STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT 19 19-Nov-19 182080824005 PATEL HIMANIBEN MANISHBHAI MRW304P 24 208 MP Quality STABILITY STUDIES AND VALIDATION OF NEFOPAM HYDROCHLORIDE IN MS. MONA CHRISTIAN 208 Assurance TABLET DOSAGE FORM Pharmaceutical STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT 20 19-Nov-19 182080824010 SHAH JAINA VIPULBHAI MRW304P 24 208 MP Quality STABILITY STUDIES AND VALIDATION OF AMINOCAPROIC ACID IN MR. HIREN KADIKAR 208 Assurance PHARMACEUTICAL DOSAGE FORM Pharmaceutical STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT 21 19-Nov-19 182080824012 SHAILY SANJAYKUMAR MODI MRW304P 24 208 MP Quality STABILITY STUDIES AND VALIDATION OF ERTUGLIFLOZIN IN PHARMACEUTICAL MS. MONA CHRISTIAN 208 Assurance DOSAGE FORM Pharmaceutical SIMULTENEOUS ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF 22 19-Nov-19 182080824003 MIRAL DOSI MRW304P 24 208 MP Quality DR. NISHA PARIKH 208 ESTIMATION CARGLUMIC ACID IN PHARMACEUTICAL DOSAGE FORM Assurance RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical SIMULTENEOUS SIMULTANEOUS ESTIMATION OF DORAVIRINE, 23 19-Nov-19 182080824004 Patel foram pareshkumar MRW304P 24 208 MP Quality DR. JITENDRA S PATEL 208 ESTIMATION LAMIVUDINE AND TENOFOVIR DISPROXIL FUMARATE IN Assurance PHARMACEUTICAL DOSAGE FORM Pharmaceutical HPTLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTENEOUS 24 19-Nov-19 182080824007 PATEL SHIVANGINI ASHWINKUMAR MRW304P 24 208 MP Quality CARICA PAPAYA L. LEAF EXTRACT IN TABLET DOSAGE MS. MONA CHRISTIAN 208 ESTIMATION Assurance FORM Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF 25 19-Nov-19 182080824009 SHAH CHARMI DIPAKKUMAR MRW304P 24 208 MP Quality IMPURITY PROFILING APREMILAST AND ITS RELATED SUBSTANCES IN TABLET DR. JITENDRA PATEL 208 Assurance DOSAGE FORM BY RP-HPLC Pharmaceutical IDENTIFICATION, SEPARATION, ISOLATION AND 26 19-Nov-19 182080824011 Shah Rajvi Nikhil MRW304P 24 208 MP Quality IMPURITY PROFILING CHARACTERIZATION OF POTENTIAL IMPURITY OF DR. NISHA PARIKH 208 Assurance EMPAGLIFLOZIN Pharmaceutical SYNTHESIS OF SYNTHESIS, CHARACTERIZATION AND SCREENING OF 27 19-Nov-19 182080824001 AANCHAL JAIN MRW304P 24 208 MP Quality OTHER (KINDLY SPECIFY) DR. NISHA PARIKH 208 BIOCONJUGATES NOVEL ANTIBIOTIC BIOCONJUGATES Assurance Pharmaceutical SYNTHESIS OF SYNTHESIS, CHARACTERIZATION AND DETERMINATION OF 28 19-Nov-19 182080824008 SHAH AAYESHA ABHAYKUMAR MRW304P 24 208 MP Quality OTHER (KINDLY SPECIFY) STATIN PHYSICOCHEMICAL PROPERTIES OF NOVEL STATIN DR. JIGNASHA DERASARI 208 Assurance CONJUGATES CONJUGATES IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF IMMEDIATE RELEASE 29 19-Nov-19 182240820001 Parmar Gaurangkumar Pankajbhai MRW304P 20 224 MP Pharmaceutics FAST MRS SEJAL M SOLANKI 224 TABLETS OF EMPAGLIFLOZIN DISPERSIBLE/DISSOLVI DELAYED/EXTENDED FORMULATION AND EVALUATION OF SUSTAINED RELEASE 30 19-Nov-19 182240820002 Patel Nihalkumar Mukeshbhai MRW304P 20 224 MP Pharmaceutics RELEASE, FLOATING, MR JAYANTI V BAJAG 224 MATRIX TABLETS OF RIVAROXABAN INSITU IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF FAST DISSOLVING 31 19-Nov-19 182240820003 Vaghela Meghana Rameshbhai MRW304P 20 224 MP Pharmaceutics FAST MRS SEJAL M SOLANKI 224 TABLETS OF BLONANSERIN DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, DESIGN, DEVELOPMENT AND EVALUATION OF 32 19-Nov-19 182280820007 SHAH ANOKHI MRW304P 20 228 MP Pharmaceutics FAST SUBLINGUAL FILMS CONTAINING SELECTED ANTI- DR. PRAFUL D. BHARADIA 228 DISPERSIBLE/DISSOLVI MUSCARINIC AGENT IR, ODT, DT, SUBLINGUAL, FORMULATION, OPTIMIZATION AND EVALUATION OF 33 19-Nov-19 182280820008 SHAH STUTEE NIMESHBHAI MRW304P 20 228 MP Pharmaceutics FAST DR. PRAFUL D. BHARADIA 228 SUBLINGUAL FILMS OF AN ANTI-HYPERTENSIVE AGENT DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION, DEVELOPMENT AND EVALUATION OF 34 19-Nov-19 182280820009 Shah Vatsal Rakeshbhai MRW304P 20 228 MP Pharmaceutics FAST DR. YAMINI D. SHAH 228 SUBLINGUAL TABLETS OF ANTI-HISTAMINIC AGENT DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION, DEVELOPMENT AND EVALUATION OF 35 19-Nov-19 182280820010 vachheta dolly nareshbhai MRW304P 20 228 MP Pharmaceutics FAST DR. YAMINI D. SHAH 228 SUBLINGUAL TABLETS OF ANTI-SPASMODIC AGENT DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION DEVELOPMENT AND EVALUATION OF 36 19-Nov-19 182280820001 ANKIT KOUL MRW304P 20 228 MP Pharmaceutics FAST SUBLINGUAL TABLETS OF SELECTED ANTI COAGULANT DR. PRAFUL D. BHARADIA 228 DISPERSIBLE/DISSOLVI AGENT. FORMULATION DEVELOPMENT AND EVALUATION OF ORAL IR, ODT, DT, SUBLINGUAL, TRANS-MUCOSAL DELIVERY SYSTEM OF ALFUZOSIN 37 19-Nov-19 182280820002 JETHA KESHAVA LAKSHMINARAYAN MRW304P 20 228 MP Pharmaceutics FAST DR. PRAFUL D. BHARADIA 228 HYDROCHLORIDE FOR TREATMENT OF BENIGN PROSTATIC DISPERSIBLE/DISSOLVI HYPERPLASIA.

Page 2 IR, ODT, DT, SUBLINGUAL, FORMULATION,DEVELOPMENT AND EVALUATION OF ORAL 38 19-Nov-19 182280820003 MAKWANA BRINDA RATNASINH MRW304P 20 228 MP Pharmaceutics FAST TRANSMUCOSAL DELIVERY SYSTEM OF ANTI-DEPRESSANT DR. RADHIKA B. PANDYA 228 DISPERSIBLE/DISSOLVI AGENT IR, ODT, DT, SUBLINGUAL, FORMULATION DEVELOPMENT AND EVALUATION OF 39 19-Nov-19 182280820004 PATEL NIDHI HARSHADBHAI MRW304P 20 228 MP Pharmaceutics FAST DR. MANISH P. PATEL 228 SUBLINGUAL TABLETS OF BETA-BLOCKING AGENT DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION DEVELOPMENT AND EVALUATION OF 40 19-Nov-19 182280820005 PRAJAPATI HIMALI JAYENDRABHAI MRW304P 20 228 MP Pharmaceutics FAST RAPID MOUTH DISSOLVING TABLETS OF ANTI- DR. MANISH P. PATEL 228 DISPERSIBLE/DISSOLVI HYPERTENSIVE AGENT. DISSOLUTION DISSOLUTION ENHANCEMENT OF BILASTINE USING 41 19-Nov-19 182280820006 RUPANI HETANSH PARESHBHAI MRW304P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY) DR. MANISH P. PATEL 228 ENHANCEMENT DIFFERENT TECHNIQUES. Pharmaceutical FORMULATION AND STANDARDIZATION OF A 42 19-Nov-19 182280824001 KATARIA JAHANVIBEN ANILKUMAR MRW304P 24 228 MP Quality HERBAL PHYTOPHARMACEUTICAL PRODUCT OF PIPER LONGUM DR. JAYANT B. DAVE 228 Assurance WITH ANTI-HYPERLIPIDEMIC ACTIVITY ANALYTICAL Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD NAVLIWALA MOHAMMADHASIL METHOD 43 19-Nov-19 182280824002 MRW304P 24 228 MP Quality OTHER (KINDLY SPECIFY) FOR ESTIMATION OF REMOGLIFLOZIN ETABONATE IN ITS DR. DR. SINDHU B EZHAVA 228 ABDULSAMAD DEVELOPMENT Assurance TABLET DOSAGE FORMS AND VALIDATION ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS FOR THE SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN 44 19-Nov-19 182280824007 SHETH PRACHI KETANKUMAR MRW304P 24 228 MP Quality DR. ANURADHA K. GAJJAR 228 ESTIMATION HYDROCHLORIDE AND LOTEPREDNOL ETABONATE IN Assurance OPHTHALMIC DOSAGE FORM

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD Pharmaceutical SIMULTENEOUS FOR ESTIMATION OF METFORMIN HYDROCHLORIDE, 45 19-Nov-19 182280824008 SURI RUCHITA HARISHCHANDRA MRW304P 24 228 MP Quality DR. SINDHU EZHAVA 228 ESTIMATION DAPAGLIFLOZIN PROPANEDIOL AND SAXAGLIPTIN Assurance HYDROCHLORIDE IN FIXED DOSE COMBINATION DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR Pharmaceutical SIMULTENEOUS ESTIMATION OF OFLOXACIN, TINIDAZOLE, TERBINAFINE 46 19-Nov-19 182280824006 RANA PINAL MAHENDRAKUMAR MRW304P 24 228 MP Quality DR. KUNJAN BODIWALA 228 ESTIMATION HYDROCHLORIDE AND CLOBETASOL PROPIONATE IN Assurance TOPICAL FORMULATION Pharmaceutical DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC IMPURITY 47 19-Nov-19 182280824003 Panchal Bhoomi Ghanshyambhai MRW304P 24 228 MP Quality OTHER (KINDLY SPECIFY) METHOD FOR ESTIMATION OF NITROSAMINE IMPURITIES DR. KUNJAN BODIWALA 228 ANALYSIS Assurance IN SELECTED PHARMACEUTICAL SUBSTANCES

DEVELOPMENT AND VALIDATION OF UV Pharmaceutical STABILITY SPECTROPHOTOMETRIC AND STABILITY INDICATING 48 19-Nov-19 182280824005 PRAJAPATI PRITI KALPESH MRW304P 24 228 MP Quality OTHER (KINDLY SPECIFY) INDICATING ASSAY DR. ANURADHA K. GAJJAR 228 CHROMATOGRAPHIC METHODS FOR THE ESTIMATION OF Assurance METHOD EVOGLIPTIN TARTRATE IN DOSAGE FORMS BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF BUCCAL TABLETS OF 49 19-Nov-19 182420820001 MAKVANA GIRISHKUMAR BHIKHBHAI MRW304P 20 242 MP Pharmaceutics TDDS, TOPICAL, DR DHAVAL J. PATEL 242 BUSPIRONE HYDROCHLORIDE HYDROGELS NASAL IR, ODT, DT, SUBLINGUAL, FORMULATION AND CHARACTERISATION OF 50 19-Nov-19 182420820002 MODI JAYKUMAR KAMLESHBHAI MRW304P 20 242 MP Pharmaceutics FAST DR S K SHAH 242 CHLORTHALIDONE LIQUISOLID COMPACTS DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION AND OPTIMIZATION OF STABLE NON- 51 19-Nov-19 182420820003 PATEL SURESHBHAI KUBERBHAI MRW304P 20 242 MP Pharmaceutics FAST DR DHAVAL J PATEL 242 AQUEOUS SOLUTION OF DOXYCYCLINE HYCLATE. DISPERSIBLE/DISSOLVI DELAYED/EXTENDED FORMULATION AND EVALUATION OF OXYBUTYNIN 52 19-Nov-19 182420820005 SHAH RAHUL VINAYKUMAR MRW304P 20 242 MP Pharmaceutics RELEASE, FLOATING, DR DHAVAL J PATEL 242 CHLORIDE OSMOTICALLY CONTROLLED RELEASE TABLETS. INSITU DELAYED/EXTENDED FORMULATION AND EVALUATION OF GASTRORETENTIVE 53 19-Nov-19 182420820006 SHAH RAJ NITINKUMAR MRW304P 20 242 MP Pharmaceutics RELEASE, FLOATING, DR S K SHAH 242 FLOATING IN SITU GEL OF FEBUXOSTAT INSITU IR, ODT, DT, SUBLINGUAL, PHYSICOCHEMICAL CHARACTERIZATION AND 54 19-Nov-19 182420820008 SHUKLA BHRANTI BHASKARBHAI MRW304P 20 242 MP Pharmaceutics FAST DISSOLUTION ENHANCEMENT OF MACITENTAN BY SOLID DR DHAVAL J PATEL 242 DISPERSIBLE/DISSOLVI DISPERSION TECHNIQUE DELAYED/EXTENDED FORMULATION AND EVALUATION OF STOMACH SPECIFIC 55 19-Nov-19 182420820009 YADAV POONAM SURESHBHAI MRW304P 20 242 MP Pharmaceutics RELEASE, FLOATING, DR SANJESH G. RATHI 242 FLOATING TABLETS OF ELUXADOLINE. INSITU

Page 3 IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF SPHERICAL CRYSTAL 56 19-Nov-19 182420820010 ZALA SEJALKUMARI ARJUNSINH MRW304P 20 242 MP Pharmaceutics FAST DR SANJESH G RATHI 242 AGGLOMERATES OF LURASIDONE HYDROCHLORIDE. DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION & STABILIZATION OF ORAL SOLID DOSAGE 57 19-Nov-19 182600820001 GODHA JIGAR GUNVANTBHAI MRW304P 20 260 MP Pharmaceutics FAST FORM OF AMINE CONTAINING DRUG HAVING CARDIO MR. HARSH J. TRIVEDI 260 DISPERSIBLE/DISSOLVI SELECTIVE BETA ADRENERGIC BLOCKING ACTIVITY DELAYED/EXTENDED DESIGN AND EVALUATION OF ONCE DAILY EXTENDED 58 19-Nov-19 182600820003 KATHIRIYA BHAGAVATIBEN VIPULBHAI MRW304P 20 260 MP Pharmaceutics RELEASE, FLOATING, DR. KUNAL N. PATEL 260 RELEASE TABLETS OF ANTIEPILEPTIC DRUG INSITU DELAYED/EXTENDED FORMULATION DEVELOPMENT AND EVALUATION OF 59 19-Nov-19 182600820006 YADAV VIPIN THANSINGH MRW304P 20 260 MP Pharmaceutics RELEASE, FLOATING, NATURAL POLYMER BASED TABLETS FOR EXTENDED MRS. BHAVANA A. PATEL 260 INSITU RELEASE OF FLUVOXAMINE MALEATE IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF RAPID 60 19-Nov-19 182620820001 ANSARI GAZALA MOHAMMEDYUSUFBHAI MRW304P 20 262 MP Pharmaceutics FAST MR. SURAJ R. CHAUHAN 262 DISINTEGRATING TABLETS OF AN ANTI-PSYCHOTIC DRUG DISPERSIBLE/DISSOLVI DELAYED/EXTENDED DEVELOPMENT AND CHARACTERIZATION OF SUSTAINED 61 19-Nov-19 182620820002 JAT MANJITSINGH NANURAM MRW304P 20 262 MP Pharmaceutics RELEASE, FLOATING, PROF. RAVI V. PATEL 262 MATRIX TABLETS OF VILDAGLIPTIN INSITU IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF ORAL 62 19-Nov-19 182620820003 QURESHI NADEEM NAJIRMAHAMMAD MRW304P 20 262 MP Pharmaceutics FAST MS. BHUMI A. RAVAL 262 DISINTEGRATING FILM OF SITAGLIPTIN PHOSPHATE DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF ORAL 63 19-Nov-19 182620820004 VASOYA VISHALBHAI BHARATBHAI MRW304P 20 262 MP Pharmaceutics FAST PROF. RAVI V. PATEL 262 DISINTEGRATING STRIP OF IVABRADINE HYDROCHLORIDE DISPERSIBLE/DISSOLVI STABILITY INDICATING ANALYTICAL METHOD Pharmaceutical CHANDALAWALA CHITRANGI DEVELOPMENT AND VALIDATION FOR THE DR. JITENDRA O. 64 19-Nov-19 182620824002 MRW304P 24 262 MP Quality STABILITY STUDIES 262 PARESHKUMAR SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND BHANGALE Assurance PIOGLITAZONE HYDROCHLORIDE IN SYNTHETIC MIXTURE

STABILITY INDICATING ANALYTICAL METHOD Pharmaceutical DEVELOPMENT AND VALIDATION FOR THE DR. JITENDRA O. 65 19-Nov-19 182620824004 LIMBACHIYA PARESHKUMAR BALDEVBHAI MRW304P 24 262 MP Quality STABILITY STUDIES 262 SIMULTANEOUS ESTIMATION OF NEBIVOLOL BHANGALE Assurance HYDROCHLORIDE AND LISINOPRIL IN SYNTHETIC MIXTURE

STABILITY INDICATING ANALYTICAL METHOD Pharmaceutical DEVELOPMENT AND VALIDATION FOR THE DR. JITENDRA O. 66 19-Nov-19 182620824005 MISHRA SWETAKUMARI HARSHNATH MRW304P 24 262 MP Quality STABILITY STUDIES 262 SIMULTANEOUS ESTIMATION OF LOSARTAN POTASSIUM BHANGALE Assurance AND ROSUVASTATIN CALCIUM IN SYNTHETIC MIXTURE STABILITY INDICATING ANALYTICAL METHOD Pharmaceutical DEVELOPMENT AND VALIDATION FOR THE DR. JITENDRA O. 67 19-Nov-19 182620824006 PADHERIYA MAITRI DILAVARSINGH MRW304P 24 262 MP Quality STABILITY STUDIES 262 SIMULTANEOUS ESTIMATION OF LISINOPRIL AND BHANGALE Assurance LOSARTAN POTASSIUM IN SYNTHETIC MIXTURE STABILITY INDICATING ANALYTICAL METHOD Pharmaceutical DEVELOPMENT AND VALIDATION FOR THE DR. JITENDRA O. 68 19-Nov-19 182620824012 SABALPARA DIVYA JAYANTILAL MRW304P 24 262 MP Quality STABILITY STUDIES 262 SIMULTANEOUS ESTIMATION OF VILDAGLIPTIN AND BHANGALE Assurance PIOGLITAZONE HYDROCHLORIDE IN SYNTHETIC MIXTURE

Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS DR. JITENDRA O. 69 19-Nov-19 182620824001 BACHCHHAV SHWETA KAILASH MRW304P 24 262 MP Quality FOR SIMULTANEOUS ESTIMATION OF DAPAGLIFLOZIN AND 262 ESTIMATION BHANGALE Assurance PIOGLITAZONE HYDROCHLORIDE IN SYNTHETIC MIXTURE

Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS DR. JITENDRA O. 70 19-Nov-19 182620824003 LIMANI GUNJAN NARENDRAKUMAR MRW304P 24 262 MP Quality FOR SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND 262 ESTIMATION BHANGALE Assurance FENOFIBRATE IN SYNTHETIC MIXTURE METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical SIMULTENEOUS BETAMETHASONE SODIUM PHOSPHATE AND DR. JITENDRA O. 71 19-Nov-19 182620824008 Patel Hinal Chhotubhai MRW304P 24 262 MP Quality 262 ESTIMATION BETAMETHASONE ACETATE IN PHARMACEUTICAL DOSAGE BHANGALE Assurance FORM BY RP-HPLC METHOD

Page 4 Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS DR. JITENDRA O. 72 19-Nov-19 182620824013 SHAH RIYABEN PRAKASHKUMAR MRW304P 24 262 MP Quality FOR SIMULTANEOUS ESTIMATION OF FOSINOPRIL SODIUM 262 ESTIMATION BHANGALE Assurance AND PRAVASTATIN SODIUM IN SYNTHETIC MIXTURE Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS DR. JITENDRA O. 73 19-Nov-19 182620824009 PATEL MRUGANK HEMENDRA MRW304P 24 262 MP Quality FOR SIMULTANEOUS ESTIMATION OF OCTREOTIDE 262 ESTIMATION BHANGALE Assurance ACETATE INJECTABLE SUSPENSION BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF LULICONAZOLE 74 20-Nov-19 182070820004 NIHAL CHANDNIWALA MRW304P 20 207 MP Pharmaceutics TDDS, TOPICAL, DR. VISHNU M. PATEL 207 TOPICAL FILM-FORMING SPRAY HYDROGELS NASAL BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF MUCOADHESIVE 75 20-Nov-19 182070820005 RAJEBHAI FAYEJABANU SIRAJAHMED MRW304P 20 207 MP Pharmaceutics TDDS, TOPICAL, BUCCAL DRUG DELIVERY OF ITRACONAZOLE FOR ORAL DR. VISHNU M. PATEL 207 HYDROGELS NASAL CANDIDIASIS DELAYED/EXTENDED PREPARATION AND EVALUATION OF OPHTHALMIC IN-SITU 76 20-Nov-19 182070820003 NADIYA SAPANABEN RAJESHBHAI MRW304P 20 207 MP Pharmaceutics RELEASE, FLOATING, DR ANAND K PATEL 207 GEL OF ITRACONAZOLE INSITU DELAYED/EXTENDED PREPARATION AND EVALUATION OF GASTRORETENTIVE IN- 77 20-Nov-19 182070820001 BHATT KRUTIBAHEN INDRAVADANBHAI MRW304P 20 207 MP Pharmaceutics RELEASE, FLOATING, DR ANAND K PATEL 207 SITU GEL OF SUCRALFATE AND OXETACAINE INSITU NANO DEVELOPMENT AND CHARACTERIZATION OF Pharmaceutical DR. ALIASGAR J 78 20-Nov-19 182230828001 PATEL RIDDHIBEN RAMESHCHANDRA MRW304P 28 223 MP SUSPENSION/EMULSION, NANOEMULSION FOR INTRANASAL DELIVERY OF 223 Technology KUNDAWALA SEDDS, LIPID BASED DDS LURASIDONE HYDROCHLORIDE

NANO DEVELOPMENT AND CHARACTERIZATION OF DRY POWDER Pharmaceutical DR. ALIASGAR J 79 20-Nov-19 182230828002 SHAH DHWANI MANISHKUMAR MRW304P 28 223 MP SUSPENSION/EMULSION, CONTAINING ROFLUMILAST PREPARED BY FREEZE DRYING 223 Technology KUNDAWALA SEDDS, LIPID BASED DDS METHOD IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF SUBLINGUAL FILMS 80 20-Nov-19 182250820003 PATEL MAHESHWARI GHANSHYAMBHAI MRW304P 20 225 MP Pharmaceutics FAST DR. KEYUR S. PATEL 225 OF CARVEDILOL DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF SUBLINGUAL FILMS 81 20-Nov-19 182250820001 KHARADI PIYUSHKUMAR JAYSINGBHAI MRW304P 20 225 MP Pharmaceutics FAST DR.SHAILESH T.PRAJAPATI 225 OF APIXABAN DISPERSIBLE/DISSOLVI DELAYED/EXTENDED FORMULATION AND EVALUATION OF DELAYED RELEASE 82 20-Nov-19 182250820002 PATEL DHRUVIL SHAILESHKUMAR MRW304P 20 225 MP Pharmaceutics RELEASE, FLOATING, DR. SHAILESH T. PRAJAPATI 225 TABLETS OF IVABRADINE HYDROCHLORIDE INSITU DELAYED/EXTENDED FORMULATION AND EVALUATION OF FLOATING TABLETS 83 20-Nov-19 182250820004 RAO AKSHAR NIKHILESHKUMAR MRW304P 20 225 MP Pharmaceutics RELEASE, FLOATING, DR. KEYUR S. PATEL 225 OF QUETIAPINE FUMARATE INSITU IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF SUBLINGUAL 84 20-Nov-19 182250820005 THAKOR NILESHKUMAR MANKAJI MRW304P 20 225 MP Pharmaceutics FAST DR. ZIL PATEL 225 TABLETS OF CLOMIPRAMINE HYDROCHLORIDE DISPERSIBLE/DISSOLVI Pharmaceutical STABILITY INDICATING CHROMATOGRAPHIC METHOD 85 20-Nov-19 182250824001 ASODIYA AXEN KIRIT MRW304P 24 225 MP Quality STABILITY STUDIES DR. SAMIR C. PATEL 225 DEVELOPMENT AND VALIDATION OF SELINEXOR IN TABLET Assurance Pharmaceutical STABILITY INDICATING CHROMATOGRAPHIC METHOD 86 20-Nov-19 182250824002 CHAUHAN BHAVESHKUMAR KHANABHAI MRW304P 24 225 MP Quality STABILITY STUDIES DEVELOPMENT AND VALIDATION OF BREMELANOTIDE IN DR. SAMIR C. PATEL 225 Assurance INJECTION Pharmaceutical STABILITY INDICATING CHROMATOGRAPHIC METHOD 87 20-Nov-19 182250824003 PATEL JANKHANABEN DINESHBHAI MRW304P 24 225 MP Quality STABILITY STUDIES DEVELOPMENT AND VALIDATION OF DOLUTEGRAVIR AND DR. DEEPA R. PATEL 225 Assurance LAMIVUDINE IN TABLET Pharmaceutical STABILITY INDICATING CHROMATOGRAPHIC METHOD 88 20-Nov-19 182250824005 PATEL USHMABEN BABUBHAI MRW304P 24 225 MP Quality STABILITY STUDIES DEVELOPMENT AND VALIDATION OF REMOGLIFLOZIN IN DR. DEEPA R. PATEL 225 Assurance TABLET Pharmaceutical STABILITY INDICATING CHROMATOGRAPHIC METHOD 89 20-Nov-19 182250824007 PRAJAPATI UTTAM MAGANLAL MRW304P 24 225 MP Quality STABILITY STUDIES DR. DEEPA R. PATEL 225 DEVELOPMENT AND VALIDATION OF ALPELISIB IN TABLET Assurance ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS FOR SIMULTANEOUS ESTIMATION OF SAXAGLIPTIN, 90 20-Nov-19 182250824004 PATEL RIPALBEN DINESHBHAI MRW304P 24 225 MP Quality DR. DEEPA R. PATEL 225 ESTIMATION DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE IN Assurance TABLET

Page 5 Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS 91 20-Nov-19 182250824006 PRAJAPATI HIMANI RAMESHBHAI MRW304P 24 225 MP Quality FOR SIMULTANEOUS ESTIMATION OF HALOBETASOL AND DR. DEEPA R. PATEL 225 ESTIMATION Assurance TANZOROTENE IN LOTION Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS 92 20-Nov-19 182250824008 RATHOD URVISHA RANJITBHAI MRW304P 24 225 MP Quality FOR SIMULTANEOUS ESTIMATION OF ALCAFTADINE AND DR. DEEPA R. PATEL 225 ESTIMATION Assurance KETOROLAC TROMETHAMINE IN EYE DROPS

NANO DEVELOPMENT AND OPTIMIZATION OF LOTEPREDNOL 93 20-Nov-19 182420820007 SHARMA PANKAJKUMAR GORAKHNATH MRW304P 20 242 MP Pharmaceutics SUSPENSION/EMULSION, DR S K SHAH 242 ETABONATE LOADED IN OPTHALMIC NANOGEL SEDDS, LIPID BASED DDS FORMULATION AND CHARACTERIZATION OF LIQUISOLID 94 20-Nov-19 182470820004 Patel Rima Sureshbhai MRW304P 20 247 MP Pharmaceutics MISCELANEOUS MR. VIJAY PATEL 247 COMPACTS OF CILOSTAZOL. FORMULATION, DEVELOPMENT AND EVALUATION OF 95 20-Nov-19 182470820001 ADHYARU PARTH GAUTAMKUMAR MRW304P 20 247 MP Pharmaceutics OTHER (KINDLY SPECIFY) CHEWABLE TABLET DR. YOGESH PATEL 247 CHEWABLE TABLETS OF NEBIVOLOL HCL IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF FAST DISSOLVING 96 20-Nov-19 182470820002 PATEL DHAVAL ASHISHBHAI MRW304P 20 247 MP Pharmaceutics FAST MR. ANIL G. RAVAL 247 SUBLINGUAL FILM OF CYANOCOBALAMIN. DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF ORALLY 97 20-Nov-19 182470820003 PATEL PRACHI RAJENDRAKUMAR MRW304P 20 247 MP Pharmaceutics FAST DISINTEGRATING FILMS OF DEXTROMETHORPHAN DR. DHARA PATEL 247 DISPERSIBLE/DISSOLVI HYDROBROMIDE USING QUALITY BY DESIGN APPROACH.

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS 98 20-Nov-19 182470824002 GOHEL VRUSHIKA RANJITSINH MRW304P 24 247 MP Quality STABILITY STUDIES MS.KUNJAL VEGAD 247 ESTIMATION OF HALOBETASOL PROPIONATE AND Assurance TAZAROTENE IN SYNTHETIC MIXTURE. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF 99 20-Nov-19 182470824003 JAGIRDAR DAYAWATI ANANTKUMAR MRW304P 24 247 MP Quality STABILITY STUDIES MS.DHWANI SHAH 247 PEXIDARTINIB IN BULK AND PHARMACEUTICAL DOSAGE Assurance FORM ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS 100 20-Nov-19 182470824004 PAEL RAJARSHREE KETANBHAI MRW304P 24 247 MP Quality STABILITY STUDIES MR.KAUSHIK PATEL 247 ESTIMATION OF KETOROLAC TROMETHAMINE AND Assurance ALCAFTADINE IN SYNTHETIC MIXTURE. STABILITY INDICATING ANALYTICAL METHOD Pharmaceutical DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF 101 20-Nov-19 182470824005 PANCHAL KRISHNA BHARATBHAI MRW304P 24 247 MP Quality STABILITY STUDIES KAUSHIK PATEL 247 REMOGLIFILOZIN BY HPLC IN BULK AND PHARMACEUTICAL Assurance DOSAGE FORMS. STABILITY INDICATING METHOD DEVELOPMENT AND Pharmaceutical VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF 102 20-Nov-19 182470824007 PATEL BHOOMI VIJAYBHAI MRW304P 24 247 MP Quality STABILITY STUDIES JAYMIN.G.PATEL 247 LESINURAD AND ALLOPURINOL BY HPLC IN BULK AND Assurance PHARMACEUTICAL DOSAGE FORMS. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical STABILITY INDICATING RP-HPLC METHOD FOR 103 20-Nov-19 182470824009 PATEL DHRUVINABEN MANOJKUMAR MRW304P 24 247 MP Quality STABILITY STUDIES MR. JAYMIN G PATEL 247 SIMULTANEOUS ESTIMATION OF ACLIDINIUM BROMIDE Assurance AND FORMOTEROL FUMARATE IN SYNTHETIC MIXTURE. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical FOR THE SIMULTANEOUS ESTIMATION OF 104 20-Nov-19 182470824010 PATEL MAITRIBAHEN JAYANTIBHAI MRW304P 24 247 MP Quality STABILITY STUDIES DOLUTEGRAVIR,EMTRICITABINE AND TENOFOVIR MS.ANKITA PATEL 247 Assurance ALAFENAMIDE BY HPLC IN BULK PHARMACEUTICAL DOSAGE FORM. BIOANALYTICAL METHOD DEVELOPMENT, METHOD Pharmaceutical VALIDATION AND STABILITY FOR ESTIMATION OF 105 20-Nov-19 182470824011 PATEL MANALIBEN SUNILBHAI MRW304P 24 247 MP Quality BIOANALYTICAL MR. JAYMIN G PATEL 247 CHLORTHALIDONE IN HUMAN PLASMA BY USING LC-ESI- Assurance MS/MS STABILITY INDICATING METHOD DEVELOPMENT AND Pharmaceutical VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF 106 20-Nov-19 182470824013 SONI POOJA HARESHKUMAR MRW304P 24 247 MP Quality STABILITY STUDIES DR.VINAY DARJI 247 ROSUVASTATIN AND VITAMIN D3 BY HPLC IN BULK AND Assurance PHARMACEUTICAL DOSAGE FORM

Page 6 CO PROCESSED, DC, DEVELOPMENT OF NEW MULTIPURPOSE DIRECTLY 107 20-Nov-19 182520820002 KADIYA PARTH DILIPKUMAR MRW304P 20 252 MP Pharmaceutics TABLET/CAPSULE COMPRESSIBLE CO-PROCESSED EXCIPIENT FOR TABLET SANJAYKUMAR S PATEL 252 EXCIPIENTS AND AT FORMULATIONS CO PROCESSED, DC, DEVELOPMENT OF NOVEL DIRECTLY COMPRESSIBLE CO- 108 20-Nov-19 182520820006 PATEL VIMALKUMAR BIPINBHAI MRW304P 20 252 MP Pharmaceutics TABLET/CAPSULE SANJAYKUMAR S PATEL 252 PROCESSED ADJUVANT FOR CHEWABLE TABLET EXCIPIENTS AND AT BUCO/MUCOADHESIVE, DESIGN, DEVELOPMENT AND OPTIMISATION OF 109 20-Nov-19 182520820003 KHAN SALAUDDIN MD OSAMA MRW304P 20 252 MP Pharmaceutics TDDS, TOPICAL, DR MAULIK R MEHTA 252 FEBUXOSTAT TRANSDERMAL PATCH HYDROGELS NASAL DELAYED/EXTENDED DESIGN AND DEVELOPMENT OF APREMILAST SUSTAINED 110 20-Nov-19 182520820001 ACHARYA AMIRAS RAJNIKANT MRW304P 20 252 MP Pharmaceutics RELEASE, FLOATING, DR ALPESHBHAI D PATEL 252 RELEASE TABLET INSITU IR, ODT, DT, SUBLINGUAL, DESIGN AND DEVELOPMENT OF ORODISPERSIBLE FILM OF 111 20-Nov-19 182520820005 PATEL MANESHKUMAR AMRUTLAL MRW304P 20 252 MP Pharmaceutics FAST DR MAULIKKUMAR J PATEL 252 LAMOTRIGINE DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION AND CHARACTERIZATION OF 112 20-Nov-19 182520820004 PATEL AFIKA JAKIRHUSEN MRW304P 20 252 MP Pharmaceutics FAST DR MAULIK R MEHTA 252 BLONANSERIN TABLET USING LIQUID SOLID TECHNIQUE DISPERSIBLE/DISSOLVI FORMULATION AND OPTIMIZATION OF MULTIPLE UNIT SHAIKH MOHAMMEDMUJAMMIL 113 20-Nov-19 182600820005 MRW304P 20 260 MP Pharmaceutics MULTIPARTICULATE PELLET SYSTEM (MUPS) OF MESALAMINE USING DR. KUNAL N. PATEL 260 JAKIRHUSEN EXTRUSION-SPHERONIZATION TECHNIQUE DEVELOPMENT AND CHARACTERIZATION OF SELF NANO EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS) OF 114 20-Nov-19 182600820002 GUPTA MONIKA ASHOKKUMAR MRW304P 20 260 MP Pharmaceutics SUSPENSION/EMULSION, DR. KUNAL N. PATEL 260 UBIDECARENONE FOR ENHANCING SOLUBILITY AND SEDDS, LIPID BASED DDS STABILITY DEVELOPMENT AND OPTIMIZATION OF PRESS-COATED PULSATILE DRUG 115 20-Nov-19 182600820004 PATEL PRUTHA KARTIK MRW304P 20 260 MP Pharmaceutics OTHER (KINDLY SPECIFY) TABLETS FOR TREATMENT OF NOCTURNAL BRONCHIAL DR. KUNAL N. PATEL 260 DELIVERY SYSTEM ASTHMA DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING RP-HPLC METHOD FOR TENOFOVIR MS. VANITA H. 116 20-Nov-19 182600824002 JIVANI VISHWA ARVINDKUMAR MRW304P 24 260 MP Quality STABILITY STUDIES 260 DISOPROXIL FUMARATE AND ITS IMPURITIES IN MARVANIYA Assurance PHARMACEUTICAL DOSAGE FORM Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 117 20-Nov-19 182600824003 PANCHAL HITAISHI JAGDISHKUMAR MRW304P 24 260 MP Quality STABILITY STUDIES INDICATING ASSAY METHOD FOR THE ESTIMATION OF DR. CHIRAG J. PATEL 260 Assurance TOFACITINIB IN TOFACITINIB EXTENDED RELEASE TABLETS

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical ELEMENTAL IMPURITIES OF AMINOCAPROIC ACID TABLETS 118 20-Nov-19 182600824005 SHAH BIJAL JITENDRAKUMAR MRW304P 24 260 MP Quality IMPURITY PROFILING AND POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS DR. CHIRAG J. PATEL 260 Assurance BY INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY (ICP-MS) Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 119 20-Nov-19 182600824004 PATEL SHRADDHABEN JAYESHKUMAR MRW304P 24 260 MP Quality STABILITY STUDIES INDICATING ASSAY RP-HPLC METHOD FOR OCTREOTIDE DR. CHIRAG J. PATEL 260 Assurance ACETATE FOR INJECTABLE SUSPENSION DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING RP-HPLC METHOD FOR TICLOPIDINE MS. VANITA H. 120 20-Nov-19 182600824006 YADAV MEENAKSHI MAHESHKUMAR MRW304P 24 260 MP Quality STABILITY STUDIES 260 HYDROCHLORIDE AND ITS IMPURITIES IN MARVANIYA Assurance PHARMACEUTICAL DOSAGE FORM IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF FAST DISSOLVING 121 20-Nov-19 182780820001 PILLAI ARCHANA ANIL MRW304P 20 278 MP Pharmaceutics FAST DR.KINJAL P. SOLANKI 278 TABLETS OF FEBUXOSTAT. DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION EVALUATION AND OPTIMIZATION OF 122 20-Nov-19 182780820002 Purohit Kusum Shankarsinh MRW304P 20 278 MP Pharmaceutics FAST DR.VIKRAM PANDYA 278 ORODISPERSIBLE FILMS OF NEBIVOLOL HYDROCHLORIDE. DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF SUBLINGUAL 123 20-Nov-19 182780820003 YADAV DIMPLE SHYAMKUMAR MRW304P 20 278 MP Pharmaceutics FAST MS.JIMMY M.LIMBACHIYA 278 TABLETS OF CINNARIZINE. DISPERSIBLE/DISSOLVI Pharmaceutical RP-HPLC METHOD DEVLOPMENT AND VALIDATION FOR METHOD 124 20-Nov-19 182780824002 NINAMA NITAKUMARI BACHUBHAI MRW304P 24 278 MP Quality OTHER (KINDLY SPECIFY) THE ESTIMATION OF FEDRATINIB IN PHARMACEUTICAL DR SANDIP DHOLAKIA 278 DEVELOPMENT Assurance DOSAGE FORM

Page 7 DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING RP-HPLC METHOD FOR THE ESTIMATION OF 125 20-Nov-19 182780824003 PATEL MANSI MUKESHKUMAR MRW304P 24 278 MP Quality STABILITY STUDIES DR RAJESH PATEL 278 REMOGLIFLOZIN ETABONATE IN ITS TABLET DOSAGE Assurance FORM Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 126 20-Nov-19 182780824001 HINGU JAGRUTI CHHAGANLAL MRW304P 24 278 MP Quality STABILITY STUDIES INDICATING RP-HPLC METHOD FOR THE ESTIMATION OF MS. DARPINI PATEL 278 Assurance ENTRECTINIB IN PHARMACEUTICAL DOSAGE FORM. BUCO/MUCOADHESIVE, FORMULATION DEVELOPMENT & EVALUATION OF KOJIC 127 20-Nov-19 182860820003 GOSWAMI SIDDHARTH MRW304P 20 286 MP Pharmaceutics TDDS, TOPICAL, DR. NISHITH PATEL 286 ACID NANOFIBRE FOR TOPICAL DELIVERY HYDROGELS NASAL NANO FORMULATION, DEVELOPMENT AND CHARACTERIZATION 128 20-Nov-19 182860820002 GAJJAR PINALBEN JITENDRABHAI MRW304P 20 286 MP Pharmaceutics SUSPENSION/EMULSION, OF PALIPERIDONE LOADED NANOSTRUCTURED LIPID MR.KRUNAL DETHOLIA 286 SEDDS, LIPID BASED DDS CARRIER

NANO FABRICATION AND OPTIMIZATION OF FEBUXOSTAT 129 20-Nov-19 182860820004 KHATRI RITIKSHA SUNILKUMAR MRW304P 20 286 MP Pharmaceutics SUSPENSION/EMULSION, LOADED NANOSTRUCTURED LIPID CARRIER BY 32 FULL MR. UMANG VARIA 286 SEDDS, LIPID BASED DDS FACTORIAL DESIGN

NANO FORMULATION DEVELOPMENT AND CHARACTERIZATION 130 20-Nov-19 182860820007 SHAH HARSH KAMLESHKUMAR MRW304P 20 286 MP Pharmaceutics SUSPENSION/EMULSION, DR. NISHITH PATEL 286 OF LEVOSULPIRIDE NANOLIPID CARRIER SEDDS, LIPID BASED DDS DEVELOPMENT OF ARTIFICAL NEURAL NETWORK FOR SR 131 20-Nov-19 182860820005 PATEL SHIVANI PRAKASHKUMAR MRW304P 20 286 MP Pharmaceutics OTHER (KINDLY SPECIFY) ANN MONOLITHIC TABLETS USING DISCRIMINATIVE MR.KRUNAL DETHOLIA 286 DISSOLUTION TEST METHOD DEVELOPMENT AND CHARACTERIZATION OF POLYMERIC 132 20-Nov-19 182860820006 PRAJAPATI MANISH PRABHUDAS MRW304P 20 286 MP Pharmaceutics MULTIPARTICULATE IDEBENONE SPHERICAL CRYSTALS BY EMULSION SOLVENT MR. UMANG VARIA 286 DIFFUSION TECHNIQUE FOR SOLUBILITY ENHANCEMENT Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 133 20-Nov-19 182860824002 CHANDEKAR YOJANA MADHUKAR MRW304P 24 286 MP Quality STABILITY STUDIES INDICATING RP-HPLC METHOD FOR ESTIMATION OF MS. MINAKSHI M. DHORU 286 Assurance FLUCLOXACILLIN SODIUM IN TABLET DOSAGE FORM DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING HPTLC METHOD FOR ESTIMATION OF 134 20-Nov-19 182860824003 KURMI AMBIKA JANARDAN MRW304P 24 286 MP Quality STABILITY STUDIES MRS. BINNY D. MEHTA 286 MIRABEGRON FROM ITS PHARMACEUTICAL Assurance FORMULATION. Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 135 20-Nov-19 182860824004 KUSHAWAHA SUNITA KAMALDEVSINGH MRW304P 24 286 MP Quality STABILITY STUDIES INDICATING HPTLC METHOD FOR ESTIMATION OF DR. PINAK R. PATEL 286 Assurance RIVAROXABAN AND ASPIRIN FROM SYNTHETIC MIXTURE.

Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 136 20-Nov-19 182860824013 YADAV VARSHA RAMKUMAR MRW304P 24 286 MP Quality STABILITY STUDIES INDICATING HPTLC METHOD FOR ESTIMATION OF MRS. BINNY D. MEHTA 286 Assurance CELECOXIB AND AMLODIPINE FROM SYTHETIC MIXTURE. DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR DETERMINATION OF AMLODIPINE 137 20-Nov-19 182860824001 BHATT JIGNA HEMANTKUMAR MRW304P 24 286 MP Quality DR. PINAK R. PATEL 286 ESTIMATION BESYLATE, ROSUVASTATIN CALCIUM AND TELMISARTAN Assurance FROM SYNTHETIC MIXTURE ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS FOR SIMULTANEOUS ESTIMATION OF SAXAGLIPTIN, 138 20-Nov-19 182860824007 PANJABI RESHMA MURLIDHAR MRW304P 24 286 MP Quality MS. MINAKSHI M. DHORU 286 ESTIMATION DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE BY Assurance HPLC IN TABLET DOSAGE FORM ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS FOR THE SIMULTANEOUS ESTIMATION OF KETOROLAC 139 20-Nov-19 182860824008 PATEL HETALBEN MULJIBHAI MRW304P 24 286 MP Quality MRS. BINNY D. MEHTA 286 ESTIMATION TROMETHAMINE AND ALCAFTADINE BY RP-HPLC FROM ITS Assurance PHARMACEUTICAL DOSAGE FORM. Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL SIMULTENEOUS 140 20-Nov-19 182860824009 PATEL JAY RAJESHBHAI MRW304P 24 286 MP Quality METHODS FOR DETERMINATION OF PREDNISOLONE AND DR. PINAK R. PATEL 286 ESTIMATION Assurance ASPIRIN FROM SYNTHETIC MIXTURE.

Page 8 Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS 141 20-Nov-19 182860824010 PATEL KHUSHBUKUMARI GUNVANTBHAI MRW304P 24 286 MP Quality FOR SIMULTANEOUS ESTIMATION OF HALOBETASOL DR. MANDEV B. PATEL 286 ESTIMATION Assurance PROPIONATE AND TAZAROTENE BY HPLC FROM LOTION

DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC Pharmaceutical SIMULTENEOUS METHOD FOR QUANTIFICATION OF FENTICONAZOLE 142 20-Nov-19 182860824012 PATEL PRIYANSHI MEHULBHAI MRW304P 24 286 MP Quality MS. MINAKSHI M. DHORU 286 ESTIMATION NITRATE AND ITS RELATED SUBSTANCES FROM SOFT Assurance GELATIN CAPSULE DOSAGE FORM Pharmaceutical PROCESS VALIDATION OF OPTIMIZED FORMULATION OF 143 20-Nov-19 182860824006 PANCHAL RIMABAHEN YOGESHBHAI MRW304P 24 286 MP Quality PROCESS VALIDATION DR. MANDEV B. PATEL 286 VILDAGLIPTIN TABLET DOSAGE FORM Assurance NANOPARTICLES DESIGN AND IN VITRO CHARACTERIZATION OF 144 21-Nov-19 182020820001 PATEL KRUPALI SHAILESHKUMAR MRW304P 20 202 MP Pharmaceutics OTHER (KINDLY SPECIFY) LOADED BUCCAL NANOPARTICLES LOADED BUCCAL FILMS: AN ATTEMPT TO DR. SAIKAT PANDE 202 FILMS ENHANCE BIOAVAILABILITY OF NIMODIPINE DEVELOPMENT, IN-VITRO CHARACTERIZATION AND NANO OPTIMIZATION OF OLMESARTAN MEDOXOMIL LOADED 145 21-Nov-19 182020820002 SHALINI DWIVEDI MRW304P 20 202 MP Pharmaceutics SUSPENSION/EMULSION, DR. AJAY B. SOLANKI 202 SNEDDS: AN ADVENT FOR ENHANCEMENT OF SEDDS, LIPID BASED DDS BIOAVAILABILITY DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical ANALYTICAL INDICATING HPTLC METHOD FOR ESTIMATION OF DR.(MRS) 146 21-Nov-19 182020824002 PATEL CHANDNI SAMIRBHAI MRW304P 24 202 MP Quality OTHER (KINDLY SPECIFY) METHOD DAPAGLIFLOZIN PROPANEDIOL AND SAXAGLIPTIN 202 ANANDKUMARI.D.CAPTAIN Assurance DEVELOPMENT HYDROCHLORIDE DIHYDRATE IN BULK AND TABLET DOSAGE FORM DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical ANALYTICAL INDICATING HPTLC METHOD FOR LORCASERIN DR.RAJENDRAKUMAR.S.M 147 21-Nov-19 182020824001 VASANI MEGHA VIRENDRAKUMAR MRW304P 24 202 MP Quality OTHER (KINDLY SPECIFY) METHOD 202 HYDROCHLORIDE HEMIHYDRATE IN BULK AND TABLET EHTA Assurance DEVELOPMENT DOSAGE FORM BUCO/MUCOADHESIVE, SYSTEMIC DEVELOPMENT OF TOPICAL VALSARTAN 148 21-Nov-19 182050820011 VAHORA MOHAMMAD TALHA MUSTUFA MRW304P 20 205 MP Pharmaceutics TDDS, TOPICAL, DR. VAISHALI T. THAKKAR 205 WOUND CARE FORMULATION HYDROGELS NASAL CO PROCESSED, DC, MICROWAVE ASSISTED SOLID DISPERSION TECHNIQUE: 149 21-Nov-19 182050820006 Pankaj Kumar MRW304P 20 205 MP Pharmaceutics TABLET/CAPSULE QUICK AND EFFICIENT METHOD TO ENHANCE DR.CHETNA D. MODI 205 EXCIPIENTS AND AT DISSOLUTION OF CILOSTAZOL STUDIES IN THE DEVELOPMENT OF SOLID ORAL DOSAGE CO PROCESSED, DC, RAULJI JAYVANTIKAKUNVERBA FORM USING INTRAGRANULAR AND EXTRAGRANULAR 150 21-Nov-19 182050820010 MRW304P 20 205 MP Pharmaceutics TABLET/CAPSULE DR. MUKESH C. GOHEL 205 DHARMPALSINH SILICON DIOXIDE AS A COMPRESSION AID ALONG WITH EXCIPIENTS AND AT BINDERS IR, ODT, DT, SUBLINGUAL, HYBRID LIQUISOLID TECHNIQUE: A NOVEL APPROACH TO 151 21-Nov-19 182050820003 Dalwadi Saloniben Bharatbhai MRW304P 20 205 MP Pharmaceutics FAST ENHANCE IN VITRO PERFORMANCE OF AN ANTIDIABETIC DR. VAISHALI T. THAKKAR 205 DISPERSIBLE/DISSOLVI DRUG COMPARATIVE EVALUATION OF TWO CONTEMPORARY IR, ODT, DT, SUBLINGUAL, METHODS FOR ENHANCING IN-VITRO DISSOLUTION OF 152 21-Nov-19 182050820005 PANCHAL SUMATI ANAMISHARAN MRW304P 20 205 MP Pharmaceutics FAST DR. VAISHALI T. THAKKAR 205 TELMISARTAN EMPLOYING THE CURRENT REGULATORY DISPERSIBLE/DISSOLVI REQUIREMENTS IR, ODT, DT, SUBLINGUAL, DEVELOPMENT OF BOSENTAN FORMULATION BY 153 21-Nov-19 182050820009 PATHAN LUKMANKHAN SHERKHAN MRW304P 20 205 MP Pharmaceutics FAST DISSOLUTION ENHANCEMENT TECHNIQUE USING DESIGN DR.CHETNA D. MODI 205 DISPERSIBLE/DISSOLVI SPACE. DESIGN AND DEVELOPMENT OF CLOZAPINE MINITABLET 154 21-Nov-19 182050820002 CHAUDHARI RUSHIKESH MRW304P 20 205 MP Pharmaceutics MULTIPARTICULATE MR. HARDIK B. RANA 205 USING QUALITY BY DESIGN APPROACH DEVELOPMENT AND CHARACTERIZATION OF CEFIXIME 155 21-Nov-19 182050820004 Limarkar Nirmalaben Manubhai MRW304P 20 205 MP Pharmaceutics MULTIPARTICULATE GRANULES BY EMPLOYING SYSTEMATIC FORMULATION DR. MUKESH C. GOHEL 205 APPROACH FOR PEDIATRIC APPLICATION

NANO SUPERSTAURATED DRUG DELIVERY SYSTEM: AN 156 21-Nov-19 182050820007 PATEL DRASHTI SUBHASHCHANDRA MRW304P 20 205 MP Pharmaceutics SUSPENSION/EMULSION, APPROACH TO ENHANCE IN-VITRO DISSOLUTION OF DR. MUKESH C. GOHEL 205 SEDDS, LIPID BASED DDS ATOVAQUONE DEVELOPMENT OF NEWER VAGINAL FORMULATION OF VAGINAL DRUG 157 21-Nov-19 182050820001 BHAVSAR NIRVISHA VIPULCHANDRA MRW304P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY) HYDROXYPROGESTERONE CAPROATE FOR THE REGULATED DR. VAISHALI T. THAKKAR 205 DELIVERY SYSTEM MARKET

Page 9 SYSTEMIC DEVELOPMENT OF PASTILLES CONTAINING 158 21-Nov-19 182050820008 PATEL GRISHMA NILESHKUMAR MRW304P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY) PASTILLATION MR. HARDIK B. RANA 205 PIPERINE AND ROSUVASTATIN SPECTROPHOTOMETRIC AND STABILITY INDICATING HIGH Pharmaceutical PERFORMANCE THIN LAYER CHROMATOGRAPHIC 159 21-Nov-19 182050824003 Padavi Sawankumar Rameshbhai MRW304P 24 205 MP Quality STABILITY STUDIES METHOD FOR SIMULTANEOUS ESTIMATION OF MR. HITESH G. RAVAL 205 Assurance FLUTICASONE PROPIONATE AND MUPIROCIN IN COMBINED DOSAGE FORM STABILITY INDICATING HIGH PERFORMANCE THIN LAYER Pharmaceutical CHROMATOGRAPHIC METHOD FOR ESTIMATION OF 160 21-Nov-19 182050824006 RATHVA PARULBEN JETHABHAI MRW304P 24 205 MP Quality STABILITY STUDIES DR. KALPANA G PATEL 205 FINGOLIMOD HYDROCHLORIDE IN PHARMACEUTICAL Assurance DOSAGE FORM AND ITS DEGRADATION KINETIC STUDY

FORMULATION QBD ASSISTED FORMULATION DEVELOPMENT AND Pharmaceutical DEVELOPMENT ANALYTICAL METHOD DEVELOPMENT FOR 161 21-Nov-19 182050824005 PATEL TRUPAL KUMARI RAJESHBHAI MRW304P 24 205 MP Quality OTHER (KINDLY SPECIFY) DR. PURVI A SHAH 205 AND METHOD SIMULTANEOUS ESTIMATION OF LEVOFLOXACIN AND Assurance DEVELOPMENT DEXAMETHASONE IN NOVEL OPHTHALMIC FORMULATION

SPECTROPHOTOMETRIC AND HIGH PERFORMANCE THIN Pharmaceutical SIMULTENEOUS LAYER CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS 162 21-Nov-19 182050824001 CHAVDA NIRALI JAGDIPBHAI MRW304P 24 205 MP Quality MR. HITESH G. RAVAL 205 ESTIMATION DETERMINATION OF MOMETASONE FUROATE AND Assurance MUPIROCIN IN COMBINED DOSAGE FORM

FORMULATION DEVELOPMENT AND SIMULTANEOUS Pharmaceutical SIMULTENEOUS ESTIMATION OF FLUTICASONE PROPIONATE AND 163 21-Nov-19 182050824002 MANIAR YASH PRADEEPBHAI MRW304P 24 205 MP Quality DR. KALPANA G PATEL 205 ESTIMATION OLOPATADINE HYDROCHLORIDE IN NEWLY OPTIMIZED Assurance NASAL FORMULATION BY QBD APPROACH DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR SIMULTANEOUS ESTIMATION OF 164 21-Nov-19 182050824007 Rathwa Nikitaben Vijaykumar MRW304P 24 205 MP Quality DR. PURVI A SHAH 205 ESTIMATION DOXOFYLLINE AND MONTELUKAST SODIUM IN Assurance PHARMACEUTICAL DOSAGE FORM IR, ODT, DT, SUBLINGUAL, SOLID DISPERSION ADSORBATE: AN EFFECTIVE METHOD Pharmaceutical 165 21-Nov-19 182130828004 PANDYA BHAVIN DIVYESHKUMAR MRW304P 28 213 MP FAST TO ENHANCE DISSOLUTION AND FLOW PROPERTIES OF DR ASHOK MAHAJAN 213 Technology DISPERSIBLE/DISSOLVI CLOZAPINE BUCO/MUCOADHESIVE, TOPICAL FOAM FORMULATION OF FLUCONAZOLE FOR 166 21-Nov-19 182130820004 KAKASANIA JEEL PINAKINBHAI MRW304P 20 213 MP Pharmaceutics TDDS, TOPICAL, DR.PRACHI PANDEY 213 SKIN FUNGAL INFECTION HYDROGELS NASAL DELAYED/EXTENDED Pharmaceutical FORMULATION AND EVALUATION OF INTRANASAL SPRAY 167 21-Nov-19 182130828003 MODI JANVIBEN KETANBHAI MRW304P 28 213 MP RELEASE, FLOATING, DR. MEENAKSHI PATEL 213 Technology OF PRAMIPEXOLE DIHYDROCHLORIDE INSITU DELAYED/EXTENDED Pharmaceutical OCULAR NANOSYSTEMS FOR PROLONGED DELIVERY OF 168 21-Nov-19 182130828006 RAIYANI DHARABEN BALUBHAI MRW304P 28 213 MP RELEASE, FLOATING, DR. NAAZNEEN SURTI 213 Technology FLURBIPROFEN AND GATIFLOXACIN INSITU NANO FORMULATION DEVELOPMENT AND OPTIMIZATION OF 169 21-Nov-19 182130820009 Shah Shrusti Sandip MRW304P 20 213 MP Pharmaceutics SUSPENSION/EMULSION, SELF NANO EMULSIFYING DRUG DELIVERY SYSTEM OF DR. ADIL PATEL 213 SEDDS, LIPID BASED DDS FUROSEMIDE

Pharmaceutical MANAGEMENT OF OVERACTIVE BLADDER IN WOMEN : 170 21-Nov-19 182130828002 Menon Maanika Kashyap MRW304P 28 213 MP MISCELANEOUS DR. MANISHA LALAN 213 Technology INTRAVAGINAL RING CONTAINING DARIFENACIN DELAYED/EXTENDED PREPARATION AND CHARACTERIZATION OF VAGINAL 171 21-Nov-19 182130820001 CHAVDA DOLLY TRIKAMLAL MRW304P 20 213 MP Pharmaceutics RELEASE, FLOATING, DR. NAAZNEEN SURTI 213 DOSAGE FORM OF AN ANTI-HIV DRUG INSITU DELAYED/EXTENDED DISSOLUTION ENHANCEMENT & COLON TARGETED 172 21-Nov-19 182130820003 KADAM RUCHITA PANDURANG MRW304P 20 213 MP Pharmaceutics RELEASE, FLOATING, DELIVERY OF NON-SYSTEMIC ANTIBIOTIC IN THE DR. MANISHA LALAN 213 INSITU MANAGEMENT OF INFLAMMATORY BOWEL DISEASE IR, ODT, DT, SUBLINGUAL, LIQUISOLID TECHNIQUE FOR DISSOLUTION 173 21-Nov-19 182130820005 MEHTA KHYATI HITESHKUMAR MRW304P 20 213 MP Pharmaceutics FAST DR ASHOK MAHAJAN 213 ENHANCEMENT OF TYROSINE KINASE INHIBITOR DISPERSIBLE/DISSOLVI FORMULATION AND EVALUATION OF NEPAFENAC Pharmaceutical 174 21-Nov-19 182130828005 PATEL DIVYA CHANDRAKANTBHAI MRW304P 28 213 MP MISCELANEOUS MICROEMULSION BASED IN-SITU GEL FOR OCULAR PAIN DR.PRIYAL PATEL 213 Technology MANAGEMENT

Page 10 FORMULATION AND EVALUATION OF MUPIROCIN AND NASAL DRUG 175 21-Nov-19 182130820002 JYOTI JHA MRW304P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY) BECLOMETHASONE INSITU GELLING BIO-ADHESIVE NASAL DR.PRIYAL R PATEL 213 DELIVERY SYSTEM FORMULATION FOR MRSA INDUCED RHINOSINUSITIS IR, ODT, DT, SUBLINGUAL, 176 21-Nov-19 182130820006 PATEL JYOTIBEN SANJAYBHAI MRW304P 20 213 MP Pharmaceutics FAST SUBLINGUAL DOSAGE FORM OF AN ANTI-EMETIC DRUG DR VANDANA PATEL 213 DISPERSIBLE/DISSOLVI VESICULAR DRUG TRANSETHOSOMAL TOPICAL GEL OF APREMILAST FOR 177 21-Nov-19 182130820007 RAHANGDALE MRUNAL GANESH MRW304P 20 213 MP Pharmaceutics DR.PRACHI PANDEY 213 DELIVERY SYSTEM TREATMENT OF PSORIASIS DELAYED/EXTENDED FORMULATION AND EVALUATION OF GASTRO RETENTIVE 178 21-Nov-19 182130820008 RAMAIYA ZEEL MAHESH MRW304P 20 213 MP Pharmaceutics RELEASE, FLOATING, DR. MEENAKSHI PATEL 213 MULTIPARTICULATE SYSTEM OF LAMOTRIGINE INSITU Pharmaceutical DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC 179 21-Nov-19 182130824001 GONDALIA ISHITA ISHWARDAS MRW304P 24 213 MP Quality STABILITY STUDIES METHODS FOR ESTIMATION OF REMOGLIFLOZIN DR. DIMAL A. SHAH 213 Assurance ETABONATE IN TABLET DOSAGE FORM Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD 180 21-Nov-19 182130824004 TEWARI AYUSHI RAHUL MRW304P 24 213 MP Quality STABILITY STUDIES FOR THE STUDY OF VARDENAFIL HYDROCHLORIDE DR. FALGUN A. MEHTA 213 Assurance TRIHYDRATE Pharmaceutical CONCEPT OF HYDROTROPY IN DEVELOPMENT AND 181 21-Nov-19 182130824003 MATUNGI BHUPENDRABHAI PATEL MRW304P 24 213 MP Quality OTHER (KINDLY SPECIFY) HYDROTROPY VALIDATION OF RP-HPLC METHOD FOR DETERMINATION DR. VANDANA B. PATEL 213 Assurance OF GATIFLOXACIN IN BULK AND EYE DROPS

DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR THE SIMULTANEOUS QUANTIFICATION OF DR. USMANGANI K. 182 21-Nov-19 182230823004 PATEL KIRTAN PINAKIN MRW304P 23 223 MP 223 Analysis ESTIMATION PERINDOPRIL ERBUMINE, INDAPAMIDE AND AMLODIPINE CHHALOTIYA BESILATE IN BULK AND PHARMACEUTICAL DOSAGE FORM

DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC Pharmaceutical SIMULTENEOUS METHODS FIMASARTAN POTASSIUM TRIHYDRATE, DR. USMANGANI K. 183 21-Nov-19 182230823001 DEVANSH KANSARA MRW304P 23 223 MP 223 Analysis ESTIMATION ROSUVASTATIN CALCIUM AND AMLODIPINE BESYLATE IN CHHALOTIYA BULK AND SYNTHETIC MIXTURE DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR THE SIMULTANEOUS ESTIMATION OF 184 21-Nov-19 182230823003 PATEL JAYKUMAR KAUSHIKBHAI MRW304P 23 223 MP MRS. JINAL TANDEL 223 Analysis ESTIMATION MINOXIDIL AND FINASTERIDE IN BULK AND MARKETED FORMULATION ANALYTICAL METHODS DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS 185 21-Nov-19 182230823002 PATEL ISHITA MANISHBHAI MRW304P 23 223 MP FOR SIMULTANEOUS ESTIMATION OF EMPAGLIFLOZIN, MRS HARSHA D JANI 223 Analysis ESTIMATION LINAGLIPTIN AND METFORMIN IN SYNTHETIC MIXTURE STABILITY INDICATING HPLC METHOD DEVELOPMENT AND Pharmaceutical VALIDATION FOR SIMULTANEOUS ESTIMATION OF 186 21-Nov-19 182240824002 Modi Palak Ghanshyambhai MRW304P 24 224 MP Quality STABILITY STUDIES DR. HIRAL PANCHAL 224 AMLODIPINE AND CELECOXIB IN PHARMACEUTICAL Assurance DOSAFE FORMS Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 187 21-Nov-19 182240824005 Shah Ami Kaushikbhai MRW304P 24 224 MP Quality STABILITY STUDIES INDICATING HPLC METHOD FOR ESTIMATION OF MRS. MITALI JASANI 224 Assurance RASAGLINE MESYLATE IN TABLETS METHOD Pharmaceutical RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR DEVELOPMENT 188 21-Nov-19 182240824001 HEENABEN MUKUNDBHAI PATEL MRW304P 24 224 MP Quality OTHER (KINDLY SPECIFY) ESTIMATION OF REMOGLIFILOZIN IN TABLET DOSAGE DR. HIRAL PANCHAL 224 AND VALIDATION Assurance FORM BY HPLC METHOD Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION DEVELOPMENT 189 21-Nov-19 182240824003 Nimavat Tanveeben Govindbhai MRW304P 24 224 MP Quality OTHER (KINDLY SPECIFY) FOR ESTIMATION OF ALPELISIB BY HPLC IN DR. HIRAL PANCHAL 224 AND VALIDATION Assurance PHARMACEUTICAL DOSAGE FORMS BY HPLC METHOD Pharmaceutical HPLC METHOD DEVELOPMENT AND VALIDATION FOR DEVELOPMENT 190 21-Nov-19 182240824004 RAVAL JEET MANOJKUMAR MRW304P 24 224 MP Quality OTHER (KINDLY SPECIFY) ESTIMATION OF PEXIDARTINIB IN PHARMACEUTICAL MRS. MITALI JASANI 224 AND VALIDATION Assurance DOSAGE FORMS BY HPLC

Page 11 METHOD Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION DEVELOPMENT 191 21-Nov-19 182240824006 Sheetal Rajendrakumar Sheth MRW304P 24 224 MP Quality OTHER (KINDLY SPECIFY) FOR ESTIMATION OF FEDRATINIB IN PHARMACEUTICAL MS. DIVYA THAKKAR 224 AND VALIDATION Assurance DOSAGE FORM BY HPLC BY HPLC DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING HPLC METHOD FOR ESTIMATION OF 192 21-Nov-19 182240824007 Tiwari Annu Rajeshkumar MRW304P 24 224 MP Quality STABILITY STUDIES DR. HIRAL PANCHAL 224 TEICOPLANIN AND ITS IMPURITIES IN PHARMACEUTICAL Assurance DOSAGE FORM DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING HPLC METHOD FOR ESTIMATION OF 193 21-Nov-19 182240824008 Tiwari Ashima Arunkumar MRW304P 24 224 MP Quality STABILITY STUDIES MS. DIVYA THAKKAR 224 VILDAGLIPTIN AND ITS IMPURITIES IN PHARMACEUTICAL Assurance DOSAGE FORM METHOD Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION DEVELOPMENT 194 21-Nov-19 182240824009 Upadhyay Kalpeshkumar Jagdishchandra MRW304P 24 224 MP Quality OTHER (KINDLY SPECIFY) FOR ESTIMATION OF TIOPRONIN IN BULK AND DR. HIRAL PANCHAL 224 AND VALIDATION Assurance PHARMACEUTICAL DOSAGE FORMS BY HPLC BY HPLC BUCO/MUCOADHESIVE, DESIGN DEVELOPMENT AND OPTIMIZATION OF 195 21-Nov-19 182350820001 JADHAV DIVYA HEMANTBHAI MRW304P 20 235 MP Pharmaceutics TDDS, TOPICAL, MUCOADHESIVE IN-SITU NASAL GEL CONTAINING DR HITESH JAIN 235 HYDROGELS NASAL XYLOMETAZOLINE HYDROCHLORIDE BUCO/MUCOADHESIVE, FORMULATION, DEVELOPMENT AND OPTIMIZATION OF 196 21-Nov-19 182350820002 SHARMA KUSUM NARESH MRW304P 20 235 MP Pharmaceutics TDDS, TOPICAL, PAROXETINE HYDROCHLORIDE LOADED TRANSDERMAL DR ASIT R SAHU 235 HYDROGELS NASAL PATCH BUCO/MUCOADHESIVE, DESIGN DEVELOPMENT AND OPTIMIZATION OF TOPICAL 197 21-Nov-19 182350820004 SHUKLA RUCHI RAJDHAR MRW304P 20 235 MP Pharmaceutics TDDS, TOPICAL, DR HITESH JAIN 235 BIGEL CONTAINING MOMETASONE FUROATE HYDROGELS NASAL BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF FUSIDIC ACID 198 21-Nov-19 182350820005 SRIVASTAVA ANKITA ASHOK MRW304P 20 235 MP Pharmaceutics TDDS, TOPICAL, DR. SHARAV DESAI 235 EMULGEL HYDROGELS NASAL DELAYED/EXTENDED FORMULATION AND CHARACTERIZATION OF SUSTAINED 199 21-Nov-19 182350820003 SHETH MAITRY SANKETKUMAR MRW304P 20 235 MP Pharmaceutics RELEASE, FLOATING, RELEASE FLOATING MICROBALLOONS CONTAINING DR HITESH JAIN 235 INSITU ALLOPURINOL DELAYED/EXTENDED FORMULATION AND EVALUATION OF IN-SITU 200 21-Nov-19 182350820008 VEEDHI RAJENDRAKUMAR RATHAWA MRW304P 20 235 MP Pharmaceutics RELEASE, FLOATING, DR SHARAV DESAI 235 OPHTHALMIC GEL CONTAINING ECONAZOLE NITRATE INSITU IR, ODT, DT, SUBLINGUAL, FORMULATION, DEVELOPMENT AND AND EVALUATION OF 201 21-Nov-19 182350820007 Trivedi Monika Vijaybhai MRW304P 20 235 MP Pharmaceutics FAST IMMEDIATE RELEASE FIXED DOSE COMBINATION OF ANTI- DR ASIT R SAHU 235 DISPERSIBLE/DISSOLVI HYPERTENSIVE AGENTS FORMULATION AND EVALUATION OF MICROSPONGE 202 21-Nov-19 182350820006 SURVE ROOSHALI SANJAY MRW304P 20 235 MP Pharmaceutics MULTIPARTICULATE DR SHARAV DESAI 235 BASED COLON SPECIFIC TABLET OF MEBENDAZOLE FORMULATION, DEVELOPMENT AND OPTIMIZATION OF 203 21-Nov-19 182350820009 VRUNDABEN PATEL MRW304P 20 235 MP Pharmaceutics MULTIPARTICULATE EXTENDED RELEASE PELLETS CONTAINING ANTI-EPILEPTIC DR ASIT R SAHU 235 DRUG ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS FOR SIMULTANEOUS ESTIMATION OF EFONIDIPINE 204 21-Nov-19 182350824001 ADESHRA SHREYA DINESHBHAI MRW304P 24 235 MP Quality MS. GRISHMA PATEL 235 ESTIMATION HYDROCHLORIDE ETHANOLATE AND TELMISARTAN IN Assurance THEIR SYNTHETIC MIXTURE Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD SIMULTENEOUS 205 21-Nov-19 182350824002 Bandwala faiz shabbirHusain MRW304P 24 235 MP Quality FOR ESTIMATION OF DRUGS IN THEIR COMBINED DOSAGE MS. GRISHMA PATEL 235 ESTIMATION Assurance FORM DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD Pharmaceutical SIMULTENEOUS FOR SIMULTANEOUS ESTIMATION OF MUPIROCIN AND 206 21-Nov-19 182350824003 CHUDASAMA VIRANGI HITESHBHAI MRW304P 24 235 MP Quality MR. TEJAS PATEL 235 ESTIMATION METHYLPREDNISOLONE IN THEIR COMBINED DOSAGE Assurance FORM Pharmaceutical PROCESS VALIDATION OF METRONIDAZOLE FILM COATED 207 21-Nov-19 182350824011 SHAH KESHA KIRANKUMAR MRW304P 24 235 MP Quality PROCESS VALIDATION DR. PRASANNA PRADHAN 235 TABLET Assurance ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS FOR SIMULTANEOUS ESTIMATION OF EFONIDIPINE 208 21-Nov-19 182350824004 daraji hitanshi pareshkumar MRW304P 24 235 MP Quality DR. PRASANNA PRADHAN 235 ESTIMATION HYDROCHLORIDE ETHANOLATE AND METOPROLOL Assurance SUCCINATE IN THEIR SYNTHETIC MIXTURE

Page 12 Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD SIMULTENEOUS 209 21-Nov-19 182350824005 KANSOTIA RUCHI MANGILAL MRW304P 24 235 MP Quality FOR SIMULTANEOUS ESTIMATION OF LULICONAZOLE AND DR. DHARA PATEL 235 ESTIMATION Assurance TERBINAFINE HCL IN PHARMACEUTICAL DOSAGE FORM DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD Pharmaceutical SIMULTENEOUS FOR SIMULTANEOUS ESTIMATION OF ACECLOFENAC, DR. PRASANNA KUMAR 210 21-Nov-19 182350824006 PARMAR RIPPLE NARENDRABHAI MRW304P 24 235 MP Quality 235 ESTIMATION TOLPERISONE AND PARACETAMOL IN TABLET PRADHAN Assurance FORMULATION Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD SIMULTENEOUS 211 21-Nov-19 182350824007 PATEL HIRALBEN KAUSHIKBHAI MRW304P 24 235 MP Quality FOR SIMULTANEOUS ESTIMATION OF ALCAFTADINE AND DR. DHARA PATEL 235 ESTIMATION Assurance KETOROLAC TROMETHAMINE IN SYNTHETIC MIXTURE.

Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS DR. PRASANNA KUMAR 212 21-Nov-19 182350824008 Patel Kajalben Jayeshkumar MRW304P 24 235 MP Quality FOR SIMULTANEOUS ESTIMATION OF AZELNIDIPINE AND 235 ESTIMATION PRADHAN Assurance TELMISARTAN IN THEIR SYNTHETIC MIXTURE

DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC Pharmaceutical SIMULTENEOUS METHOD FOR SIMULTANEOUS ESTIMATION OF DR. DHANANJAY 213 21-Nov-19 182350824009 Patel khyati jayendrabhai MRW304P 24 235 MP Quality 235 ESTIMATION ATORVASTATIN CALCIUM AND VITAMIN D3 MESHRAM Assurance (CHOLECALCIFEROL) IN THEIR COMBINED DOSAGE FORM

Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD SIMULTENEOUS 214 21-Nov-19 182350824010 Radharapu Satchitkrishna Chandrashekhar MRW304P 24 235 MP Quality FOR SIMULTANEOUS ESTIMATION OF PAROXETINE HCL DR. DHARA PATEL 235 ESTIMATION Assurance AND ETIZOLAM IN PHARMACEUTICAL DOSAGE FORM IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF FAST DISSOLVING 215 21-Nov-19 182440820001 Gandhi Rukma Shishirkumar MRW304P 20 244 MP Pharmaceutics FAST M. RAHIL BHURA 244 ORAL FILM OF ANTIPSHYCHOTIC AGENT PALIPERIDONE. DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF SUBLINGUAL TABLET 216 21-Nov-19 182440820002 Jayswal Durgeshkumar Dipakkumar MRW304P 20 244 MP Pharmaceutics FAST M. RAHIL BHURA 244 OF BUSPIRONE HYDROCHLORIDE DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF FAST DISSOLVING 217 21-Nov-19 182440820003 Solanki Nikulkumar Raghabhai MRW304P 20 244 MP Pharmaceutics FAST MEHUL VYAS 244 FILM OF IVABRADINE HCL DISPERSIBLE/DISSOLVI DELAYED/EXTENDED FORMULATION AND EVALUATION OF SUSTAINED RELEASE 218 21-Nov-19 182450820001 ARYA UDAYKUMAR KISHANLAL MRW304P 20 245 MP Pharmaceutics RELEASE, FLOATING, DR. P. H. PRAJAPATI 245 TABLET OF CLOMIPRAMINE INSITU Pharmaceutical QUANTITATIVE QUANTITATIVE ANALYTICAL METHOD DEVELOPMENT AND 219 21-Nov-19 182450824003 PATEL KRUPABEN NARESHKUMAR MRW304P 24 245 MP Quality OTHER (KINDLY SPECIFY) METHOD VALIDATION FOR TERIFLUNOMIDE IN PHARMACEUTICAL DR. LAXMAN M PRAJAPATI 245 Assurance DEVELOPMENT DOSAGE FORM Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION METHOD 220 21-Nov-19 182450824001 Akhani Vaibhavi Nitinkumar MRW304P 24 245 MP Quality OTHER (KINDLY SPECIFY) FOR ESTIMATION OF PRUCALOPRIDE SUCCINATE IN DR. LAXMAN M PRAJAPATI 245 DEVELOPMENT Assurance PHARMACEUTICAL DOSAGE FORM Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION DR. CHHAGANBHAI N 221 21-Nov-19 182450824004 SANYAL ASTHA PRAVINBHAI MRW304P 24 245 MP Quality OTHER (KINDLY SPECIFY) QBD APPROACH FOR SAROGLITAZAR IN PHARMACEUTICAL DOSAGE FORM 245 PATEL Assurance BY QBD APPROACH

Pharmaceutical STABILITY INDICATING ANALYTICAL METHOD MR. PRUTHVIRAJ K 222 21-Nov-19 182450824005 Shah Hemant Yogeshbhai MRW304P 24 245 MP Quality STABILITY STUDIES DEVELOPMENT AND VALIDATION FOR ESTIMATION OF 245 CHAUDHARY Assurance ZONISAMIDE IN PHARMACEUTICAL DOSAGE FORM Pharmaceutical STABILITY INDICATING ANALYTICAL METHOD DR. CHHAGANBHAI N 223 21-Nov-19 182450824002 PATEL ARATIBEN MANUBHAI MRW304P 24 245 MP Quality STABILITY STUDIES DEVELOPMENT AND VALIDATION FOR ESTIMATION OF 245 PATEL Assurance BILASTINE IN PHARMACEUTICAL DOSAGE FORM PART A: PREPARATION AND SCREENING OF BOTANICAL FORMULATIONS WITH ANTI- ACNE POTENTIAL. PART B: 224 22-Nov-19 182280826001 FEFAR NIDHIBEN RAMESHBHAI MRW304P 26 228 MP Pharmacognosy HERBAL RESEARCH DR. MAMTA B SHAH 228 ISOLATION OF MAJOR COUMARIN/S FROM PLEUROSPERMUM ANGELICOIDES.

PART A: ISOLATION OF BIOACTIVES FROM CRATAEVA 225 22-Nov-19 182280826002 JHALA SHAILJA BALBHADRASINH MRW304P 26 228 MP Pharmacognosy HERBAL RESEARCH NURVALA. PART B: DEVELOPMENT AND EVALAUTION OF DR. MAMTA B SHAH 228 MOSQUITO REPELLENT HERBAL FORMULATION.

Page 13 PART A: DEVELOPMENT AND ANALYSIS OF HERBAL ANTI 226 22-Nov-19 182280826003 Soni Bhoomi Paraskumar MRW304P 26 228 MP Pharmacognosy HERBAL RESEARCH AGING SKIN CARE PRODUCTS PART B: ISOLATION OF DR. MAMTA B SHAH 228 MAJOR BIOACTIVE FROM GARCINIA INDICA. PART A: DEVELOPMENT OF HERBAL SUPPLEMENT FOR TATMA SHAMBHUKUMAR DIABETES MITIGATION. PART B: METHOD DEVELOPMENT 227 22-Nov-19 182280826004 MRW304P 26 228 MP Pharmacognosy HERBAL RESEARCH DR. MAMTA B SHAH 228 SHRIBALKRISHNADAS FOR ISOLATION OF PHENOLIC CONSTITUENT/S OF PSORALEA CORYLIFOLIA. BUCO/MUCOADHESIVE, DEVELOPMENT, EVALUATION AND OPTIMIZATION OF 228 22-Nov-19 182390820009 PATEL HEMAXIBEN HITENDRA MRW304P 20 239 MP Pharmaceutics TDDS, TOPICAL, DACARBAZINE LOADED SOLID LIPID NANOPARTICLE BASED DR. KOMAL PARMAR 239 HYDROGELS NASAL TOPICAL GEL IR, ODT, DT, SUBLINGUAL, FORMULATION AND CHARACTERIZATION OF SPHERICAL 229 22-Nov-19 182390820004 HALPATI KARTIK THAKORBHAI MRW304P 20 239 MP Pharmaceutics FAST AGGLOMERATES FOR SOLUBILITY ENHANCEMENT OF THE DR. HITESH DALVADI 239 DISPERSIBLE/DISSOLVI ABIRATERONE ACETATE USING QBD APPROACH IR, ODT, DT, SUBLINGUAL, DEVELOPMENT AND OPTIMIZATION OF ORALLY 230 22-Nov-19 182390820005 Joshi Chaitanya harshadkumar MRW304P 20 239 MP Pharmaceutics FAST MR. TULARAM BAROT 239 DISINTEGRATING FILM DISPERSIBLE/DISSOLVI DELAYED/EXTENDED DEVELOPMENT AND CHARACTERIZATION OF INTRANASAL 231 22-Nov-19 182390820006 MAURAYA RAJESHKUMAR KRUPASANKAR MRW304P 20 239 MP Pharmaceutics RELEASE, FLOATING, IN SITU GEL OF NANOPARTICULATED POLYMERIC DR. KOMAL PARMAR 239 INSITU CARRIERS CONTAINING TEMOZOLOMIDE DELAYED/EXTENDED DEVELOPMENT AND EVALUATION OF IN-SITU GEL FOR THE 232 22-Nov-19 182390820008 PATEL DEVYANGI PRAKASH MRW304P 20 239 MP Pharmaceutics RELEASE, FLOATING, MR. TULARAM BAROT 239 TREATMENT OF GASTRIC ULCER INSITU DELAYED/EXTENDED DESIGN AND CHARACTERIZATION OF IRINOTECAN 233 22-Nov-19 182390820011 SOLANKI HARDIK MAHENDRASINH MRW304P 20 239 MP Pharmaceutics RELEASE, FLOATING, HYDROCHLORIDE LOADED COLON TARGETED BEADS DR. HITESH DALVADI 239 INSITU USING QBD APPROACH DELAYED/EXTENDED FORMULATION AND CHARACTERIZATION OF INJECTABLE 234 22-Nov-19 182390820012 YADAV SUNITA ACHCHHELAL MRW304P 20 239 MP Pharmaceutics RELEASE, FLOATING, IN-SITU IMPLANT DRUG DELIVERY FOR ANTICANCER DRUG DR. HITESH DALVADI 239 INSITU OF ABIRATERONE ACETATE NANO DEVELOPMENT AND CHARACTERIZATION OF EXEMESTANE 235 22-Nov-19 182390820002 DHONDE BHOOMI YOGESHKUMAR MRW304P 20 239 MP Pharmaceutics SUSPENSION/EMULSION, DR. KOMAL PARMAR 239 LOADED LIPID-POLYMER HYBRID NANOPARTICLES SEDDS, LIPID BASED DDS DEVELOPMENT AND OPTIMIZATION OF SPHERICAL 236 22-Nov-19 182390820003 HALPATI DIPESHBHAI GANPATBHAI MRW304P 20 239 MP Pharmaceutics MISCELANEOUS MR. TULARAM BAROT 239 AGGLOMERATES OF CLOZAPINE NANO DEVELOPMENT, EVALUATION AND OPTIMIZATION OF LIPID 237 22-Nov-19 182390820007 MAV URVI GOPALBHAI MRW304P 20 239 MP Pharmaceutics SUSPENSION/EMULSION, POLYMER HYBRID NANOPARTICLE BASED INHALER DR. KOMAL PARMAR 239 SEDDS, LIPID BASED DDS CONTAINING PYRAZINAMIDE DEVELOPMENT AND CHARACTERIZATION OF GEMCITABINE 238 22-Nov-19 182390820010 PATEL YASH VIJAYKUMAR MRW304P 20 239 MP Pharmaceutics MULTIPARTICULATE DR. KOMAL PARMAR 239 NANOPARTICLES SIMULTANEOUS ESTIMATION OF FUSIDIC ACID AND Pharmaceutical SIMULTENEOUS BECLOMETHASONE DIPROPIONATE BY 239 22-Nov-19 182390824001 ANCHAL SINGH MRW304P 24 239 MP Quality MRS.MADHURI HINGE 239 ESTIMATION CHROMATOGRAPHIC METHOD IN THEIR Assurance PHARMACEUTICAL DOSAGE FORM DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR SIMULTANEOUS ESTIMATION OF TIMOLOL 240 22-Nov-19 182390824002 Bhandari Truptiben Ramjibhai MRW304P 24 239 MP Quality DR. ALISHA PATEL 239 ESTIMATION MALEATE AND PILOCARPINE NITRATE IN COMBINED Assurance DOSAGE FORM Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND ITS SIMULTENEOUS 241 22-Nov-19 182390824003 DESAI ANAL PARIMAL MRW304P 24 239 MP Quality VALIDATION FOR ESTIMATION OF NADIFLOXACIN AND MRS. SHUCHI DESAI 239 ESTIMATION Assurance ADAPALENE IN THEIR COMBINED TOPICAL FORMULATION. METHODS DEVELOPMENT AND VALIDATION FOR Pharmaceutical SIMULTENEOUS SIMULTANEOUS ESTIMATION OF HYDROCORTISONE 242 22-Nov-19 182390824004 DESAI SALONI SANJAYBHAI MRW304P 24 239 MP Quality DR. ALISHA PATEL 239 ESTIMATION ACETATE AND ATROPINE SULPHATE IN MARKETED Assurance FORMULATION DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR SIMULTANEOUS ESTIMATION OF 243 22-Nov-19 182390824005 Dhodi Khyati Khalpa MRW304P 24 239 MP Quality DR. ALISHA PATEL 239 ESTIMATION LEVOFLOXACIN AND PREDNISOLONE ACETATE IN Assurance SYNTHETIC MIXTURE

Page 14 Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS 244 22-Nov-19 182390824006 NAIK SHREYA NARESHBHAI MRW304P 24 239 MP Quality FOR SIMULTANEOUS ESTIMATION OF NADIFLOXACIN AND MRS. SHUCHI DESAI 239 ESTIMATION Assurance MOMETASONE FUROATE IN SEMISOLID DOSAGE FORM.

DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR SIMULTANEOUS ESTIMATION OF 245 22-Nov-19 182390824007 PARMAR DRASTI MUKESHSINH MRW304P 24 239 MP Quality MRS. MADHURI HINGE 239 ESTIMATION NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE IN Assurance PHARMACEUTICAL DOSAGE FORM DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR CLOBETASOL PROPIONATE AND 246 22-Nov-19 182390824008 PATEL KHUSHBU BHARATBHAI MRW304P 24 239 MP Quality MRS. MEGHA SHAH 239 ESTIMATION CLOTRIMAZOLE IN THEIR COMBINED PHARMACEUTICAL Assurance DOSAGE FORM. SIMULTANEOUS ESTIMATION OF METFORMIN Pharmaceutical SIMULTENEOUS HYDROCHLORIDE AND ALPHA LIPOIC ACID BY 247 22-Nov-19 182390824009 PATEL PRACHIBEN JITENDRABHAI MRW304P 24 239 MP Quality MRS.MADHURI HINGE 239 ESTIMATION CHROMATOGRAPHIC METHOD IN PHARMACEUTICAL Assurance DOSAGE FORM DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR SIMULTANEOUS ESTIMATION OF 248 22-Nov-19 182390824010 PATEL PREETI DILIP MRW304P 24 239 MP Quality MRS.MADHURI HINGE 239 ESTIMATION ARIPIPRAZOLE AND ESCITALOPRAM OXALATE IN Assurance SYNTHETIC MIXTURE DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR SIMULTANEOUS ESTIMATION OF 249 22-Nov-19 182390824011 PATEL PRIYABEN BIPINBHAI MRW304P 24 239 MP Quality MS. RAJVI MAHIDA 239 ESTIMATION HYDROCORTISONE ACETATE AND CHLORAMPHENICOL IN Assurance THEIR COMBINED DOSAGE FORM ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS FOR THE SIMULTANEOUS ESTIMATION OF FLUCONAZOLE 250 22-Nov-19 182390824012 PATEL RUPALI RAVINDRABHAI MRW304P 24 239 MP Quality MRS. MEGHA SHAH 239 ESTIMATION AND ZINC PYRITHIONE IN THEIR COMBINED MARKETED Assurance FORMULATION. DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR SIMULTANEOUS ESTIMATION OF 251 22-Nov-19 182390824013 Patel Trigal Jayeshbhai MRW304P 24 239 MP Quality MRS.MADHURI HINGE 239 ESTIMATION CLOBETASOL PROPIONATE AND MICONAZOLE NITRATE IN Assurance THEIR COMBINED DOSAGE FORM DEVELOPMENT AND VALIDATION OF ANALYTICAL Pharmaceutical SIMULTENEOUS METHODS FOR SIMULTANEOUS ESTIMATION OF 252 22-Nov-19 182390824014 PRAJAPATI RITA BHAGVANDAS MRW304P 24 239 MP Quality MS.RAJVI MAHIDA 239 ESTIMATION HYDROCORTISONE ACETATE, BENZOIC ACID AND SALICYLIC Assurance ACID IN THEIR PHARMACEUTICAL DOSAGE FORM

Pharmaceutical ANALYTICAL METHODS DEVELOPMENT AND VALIDATION SIMULTENEOUS 253 22-Nov-19 182390824015 ZALAK DESAI MRW304P 24 239 MP Quality FOR SIMULTANEOUS ESTIMATION OF SODIUM BENZOATE DR.ALISHA PATEL 239 ESTIMATION Assurance AND SODIUM PHENYLACETATE IN SYNTHETIC MIXTURE BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF SERTACONAZOLE 254 22-Nov-19 182540820001 BHARODIYA KISHAN VITTHALBHAI MRW304P 20 254 MP Pharmaceutics TDDS, TOPICAL, DR. MANISH GOYANI 254 NITRATE EMULGEL FOR TOPICAL DRUG DELIVERY HYDROGELS NASAL BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF TOPICAL SPRAY FOR 255 22-Nov-19 182540820003 KOLYA MEHRUNNISHA MAHAMAD MRW304P 20 254 MP Pharmaceutics TDDS, TOPICAL, DR. MANISH GOYANI 254 THE TREATMENT OF FUNGAL INFECTION HYDROGELS NASAL BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF BIFONAZOLE 256 22-Nov-19 182540820006 PATEL PINKISABEN SUBHASHBHAI MRW304P 20 254 MP Pharmaceutics TDDS, TOPICAL, DR. MANISH GOYANI 254 ETHOSOMAL GEL FOR TOPICAL DRUG DELIVERY HYDROGELS NASAL BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF CYCLOSPORINE 257 22-Nov-19 182540820008 SINGH SHIKHAKUMARI VINOD MRW304P 20 254 MP Pharmaceutics TDDS, TOPICAL, DR. MANISH GOYANI 254 TRANSFEROSOMAL GEL FOR TOPICAL DRUG DELIVERY HYDROGELS NASAL BUCO/MUCOADHESIVE, PREPARATION AND EVALUATION OF CITRIC ACID CROSS 258 22-Nov-19 182540820007 RATHWA SURDAS KHUMANBHAI MRW304P 20 254 MP Pharmaceutics TDDS, TOPICAL, LINKED GELLAN GUM BASED HYDROGEL FOR DRUG DR. ANAND DESHMUKH 254 HYDROGELS NASAL DELIVERY DEVELOPMENT AND COMPARATIVE EVALUATION OF NANO COMPOSITE 259 22-Nov-19 182540820004 PANDYA PRIYANKA HARSHADBHAI MRW304P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY) ORGANICALLY MODIFIED NANO-COMPOSITE CLAY BASED MR. SUSHIL RAUT 254 SYSTEMS GELS FOR TREATMENT OF ARTHRITIS

Page 15 FORMULATION AND CHARACTERIZATION OF NANO- NANO COMPOSITE 260 22-Nov-19 182540820005 PATEL JINALKUMARI RAJESHBHAI MRW304P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY) COMPOSITE CLAY-DRUG COMPLEXES FOR ORAL DELIVERY MR. SUSHIL RAUT 254 SYSTEMS OF IBUPROFEN DEVELOPMENT AND COMPARISON OF POLYMERIC GELS NANO COMPOSITE 261 22-Nov-19 182540820009 TIWARI PRATIBHA AJAY MRW304P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY) CONTAINING NANO-COMPOSITE CLAY-DRUG HYBRID MR. SUSHIL RAUT 254 SYSTEMS SYSTEM FOR WOUND HEALING NANO FORMULATION AND EVALUATION OF NANOEMULSION 262 22-Nov-19 182540820002 JADAV VISHALSING RAJESING MRW304P 20 254 MP Pharmaceutics SUSPENSION/EMULSION, FOR ORAL BIOAVAILABILITY ENHANCEMENT OF MR. SUSHIL RAUT 254 SEDDS, LIPID BASED DDS LORATADINE

NANO DESIGN AND DEVELOPMENT OF ZOLMITRIPTAN LOADED 263 22-Nov-19 182570820001 BHOJ HETAL DINESHBHAI MRW304P 20 257 MP Pharmaceutics SUSPENSION/EMULSION, NANOSTRACTURED LIPID CARRIERS (NLC) FOR TREATMENT DR. ARA T. PATEL 257 SEDDS, LIPID BASED DDS OF MIGRAINE Pharmaceutical DEVELOPMENT AND VALIDATION OF BIOANALYTICAL 264 22-Nov-19 182570824002 KHATRI VANITA AMARSINGH MRW304P 24 257 MP Quality BIOANALYTICAL METHOD FOR ESTIMATION OF ORCIPRENALINE SULPHATE OJAS PATEL 257 Assurance IN RAT PLASMA BY LC-MS/MS Pharmaceutical ANNUAL PRODUCT QUALITY REVIEW (APQR) OF 265 22-Nov-19 182570824003 MANOJKUMAR MRW304P 24 257 MP Quality PROCESS VALIDATION DR. HARSHA U. PATEL 257 TOPIRAMATE TABLETS USP 200 MG Assurance Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION METHOD 266 22-Nov-19 182570824001 HARMANI NIRAV JAYSUKHBHAI MRW304P 24 257 MP Quality OTHER (KINDLY SPECIFY) FOR THE ESTIMATION OF DAROLUTAMIDE BY HPLC IN DR. HARSHA U. PATEL 257 DEVELOPMENT Assurance BULK AND PHARMACEUTICAL DOSAGE FORM

Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION METHOD 267 22-Nov-19 182570824004 PANCHAL PUJA RAMESHBHAI MRW304P 24 257 MP Quality OTHER (KINDLY SPECIFY) FOR THE ESTIMATION OF PEXIDARTINIB BY HPLC IN BULK NEHA S. MOCHI 257 DEVELOPMENT Assurance AND PHARMACEUTICAL DOSAGE FORM PREPARATION AND EVALUATION OF POLY-HERBAL 268 22-Nov-19 182600826001 VACHHANI TWINKLE MAHESHBHAI MRW304P 26 260 MP Pharmacognosy HERBAL RESEARCH MRS. PAYAL SUTHAR 260 FORMULATION FOR ARTHRITIS BUCO/MUCOADHESIVE, FORMULATION,DEVELOPMENT AND EVALUATION OF DR. ANURADHA P. 269 22-Nov-19 182650820002 MODI KSHEMUBEN SATISHKUMAR MRW304P 20 265 MP Pharmaceutics TDDS, TOPICAL, MICROEMULGEL OF EBERCONAZOLE FOR TOPICAL DRUG 265 PRAJAPATI HYDROGELS NASAL DELIVERY BUCO/MUCOADHESIVE, DESIGN AND CHARACTERIZATION OF TRANSDERMAL 270 22-Nov-19 182650820001 Bhamtikar Krutik Kanti MRW304P 20 265 MP Pharmaceutics TDDS, TOPICAL, DR.KANTILAL B. NARKHEDE 265 PATCH OF CLOXACILLINE SODIUM HYDROGELS NASAL BUCO/MUCOADHESIVE, FORMULATION,DEVELOPMENT AND EVALUATION OF DR. ANURADHA P. 271 22-Nov-19 182650820004 PATEL HARSHALKUMAR MAGANBHAI MRW304P 20 265 MP Pharmaceutics TDDS, TOPICAL, 265 NASAL SPAY CONTAINING ANTI HISTAMINIC DRUG PRAJAPATI HYDROGELS NASAL CO PROCESSED, DC, FORMULATION AND EVALUATION OF NANOPARTICLE 272 22-Nov-19 182650820003 NADA CHIRAG DHIRUBHAI MRW304P 20 265 MP Pharmaceutics TABLET/CAPSULE LOADED DRUG DELIVERY FOR IMPROVING IN VITRO DRUG MR.AJAY N.TALELE 265 EXCIPIENTS AND AT RELEASE OF ANTIMALARIAL DRUG CO PROCESSED, DC, FORMULATION ,DEVELOPMENT AND EVALUATION ANTI DR. KANTILAL B. 273 22-Nov-19 182650820005 PATEL SAVANKUMAR PRAVINBHAI MRW304P 20 265 MP Pharmaceutics TABLET/CAPSULE 265 ASTHMATIC DRUG IN LOZENGES NARKHEDE EXCIPIENTS AND AT IR, ODT, DT, SUBLINGUAL, FORMULATION,DEVELOPMENT AND EVALUATION OF AN 274 22-Nov-19 182650820006 SINHA SWATE ABHAY MRW304P 20 265 MP Pharmaceutics FAST IMMEDIATE RELEASE ANTIGOUT DRUG FOR TREATMENT MR. AJAY N. TALELE 265 DISPERSIBLE/DISSOLVI OF ACUTE GOUT DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING RP-HPLC METHOD FOR THE ESTIMATION OF 275 22-Nov-19 182650824001 AHIR HETVIBEN MANGUBHAI MRW304P 24 265 MP Quality STABILITY STUDIES DR. D. P. DAMAHE 265 EVOGLIPTIN TARTRATE IN PHARMACEUTICAL DOSAGE Assurance FORM Pharmaceutical BIOANALYTICAL METHOD DEVELOPMENT AND 276 22-Nov-19 182650824007 PATEL HEMANGI ARVINDBHAI MRW304P 24 265 MP Quality BIOANALYTICAL VALIDATION FOR ESTIMATION OF AZILSARTAN IN K3EDTA DR. SACHIN B. NARKHEDE 265 Assurance HUMAN PLASMA BY USING LC-ESI-MS-MS Pharmaceutical SIMULTANEOUS ESTIMATION OF LOSARTAN POTASSIUM, SIMULTENEOUS 277 22-Nov-19 182650824006 PATEL DRASTI ANUPBHAI MRW304P 24 265 MP Quality AMLODIPINE BESYLATE AND CHLORTHALIDONE BY RP- DR. SHAILESH V LUHAR 265 ESTIMATION Assurance HPLC METHOD ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical SIMULTENEOUS AMBROXOL HYDROCHLORIDE, CHLORPHENIRAMINE 278 22-Nov-19 182650824005 PAREKH KALGI DIVYESH MRW304P 24 265 MP Quality DR. SHAILESH V LUHAR 265 ESTIMATION MALEATE AND DEXTROMETHORPHAN HYDROBROMIDE IN Assurance COMBINED DOSAGE FORM

Page 16 METHOD DEVELOPMENT AND VALIDATION OF Pharmaceutical SIMULTENEOUS DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE 279 22-Nov-19 182650824004 GORI HAYA AMBALAL MRW304P 24 265 MP Quality DR. SHAILESH V LUHAR 265 ESTIMATION AND CHLORPHENIRAMINE MALEATE IN COMBINED Assurance DOSAGE FORM BY HPTLC Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SIMULTENEOUS 280 22-Nov-19 182650824003 DHIMMAR MAITRI NAVINCHANDRA MRW304P 24 265 MP Quality METRONIDAZOLE, FURAZOLIDONE AND DICYCLOMINE DR. SACHIN B. NARKHEDE 265 ESTIMATION Assurance HYDROCHLORIDE IN TABLET DOSAGE FORM BY HPTLC

Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SIMULTENEOUS 281 22-Nov-19 182650824008 PATEL KRINA SURYAKANT MRW304P 24 265 MP Quality TELMISARTAN AND BENIDIPINE HYDROCHLORIDE IN DR. D. P. DAMAHE 265 ESTIMATION Assurance PHARMACEUTICAL DOSAGE FORM BY HPTLC ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS FOR ESTIMATION OF CILNIDIPINE AND BISOPROLOL 282 22-Nov-19 182650824002 BAGDA NISHA DINESH MRW304P 24 265 MP Quality DR.D.P.DAMAHE 265 ESTIMATION FUMARATE IN PHARMACEUTICAL DOSAGE FORM BY HPTLC Assurance . QBD APPROACH, APPLICATION OF NOVEL QBD APPROACH IN ANALYTICAL Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DR. BHARATKUMAR 283 22-Nov-19 182670824001 VISHAL KUMAR PATHAK MRW304P 24 267 MP Quality OTHER (KINDLY SPECIFY) METHOD 267 QUANTITATIVE ANALYSIS OF CO-ENZYME Q10 IN SINGLE GANESHBHAI CHAUDHARI Assurance DEVELOPMENT AND COMBINED DOSAGE FORMS AND VALIDATION BUCO/MUCOADHESIVE, PREPARATION, OPTIMIZATION AND EVALUATION OF 284 22-Nov-19 182680820002 CHAUDHARY PRIYAVANDA BIPINBHAI MRW304P 20 268 MP Pharmaceutics TDDS, TOPICAL, ACYCLOVIR LOADED MICROEMULSION GEL FOR TOPICAL DR. DIXIT C MODI 268 HYDROGELS NASAL DELIVERY FORMULATION AND EVALUATION OF NANOCARRIERS BUCO/MUCOADHESIVE, LOADED WITH CALCITONIN FOR ANTIRESORPTIVE 285 22-Nov-19 182680820003 MISTRY STUTIBEN NARESHKUMAR MRW304P 20 268 MP Pharmaceutics TDDS, TOPICAL, MRS. SONAL N SOLANKI 268 TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS HYDROGELS NASAL INTRANASALLY BUCO/MUCOADHESIVE, EXPLORATION OF CLEARGEL TECHNOLOGY FOR ENHANCED 286 22-Nov-19 182680820001 Basavaraj Savanoor MRW304P 20 268 MP Pharmaceutics TDDS, TOPICAL, DR. DHIREN P SHAH 268 TOPICAL DELIVERY OF POORLY SOLUBLE DRUG. HYDROGELS NASAL BUCO/MUCOADHESIVE, DESIGN,DEVELOPMENT AND CHARACTERIZATION OF 287 22-Nov-19 182680820004 PATEL DHRUVKUMAR NILESHBHAI MRW304P 20 268 MP Pharmaceutics TDDS, TOPICAL, MR. TEJAS J PATEL 268 NANOPARTICLE LOADED TOPICAL GEL OF APREMILAST. HYDROGELS NASAL BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF MUCOADHESIVE DR. JITENDRA SINGH 288 22-Nov-19 182680820006 PATEL MOHINIBEN SHAILESHBHAI MRW304P 20 268 MP Pharmaceutics TDDS, TOPICAL, 268 VAGINAL FILM OF OXYBUTYNIN YADAV HYDROGELS NASAL BUCO/MUCOADHESIVE, NANOEMULSION BASED HYDROGEL OF LULICONAZOLE : 289 22-Nov-19 182680820011 THAKOR HELI NILAYKUMAR MRW304P 20 268 MP Pharmaceutics TDDS, TOPICAL, DR. RUMIT M SHAH 268 AN INNOVATIVE APPROACH FOR TOPICAL DRUG DELIVERY HYDROGELS NASAL CAN PHARMACEUTICAL WAXES BE SOLUBILIZER FOR DR. JITENDRA SINGH 290 22-Nov-19 182680820009 SINGH NEHA GOPAL MRW304P 20 268 MP Pharmaceutics MISCELANEOUS 268 DRUGS. “ A FEASIBILITY STUDY” YADAV DELAYED/EXTENDED DESIGN, DEVELOPMENT AND EVALUATION OF MULTIPLE- DR. JITENDRA SINGH 291 22-Nov-19 182680820005 PATEL HARSH DILIPKUMAR MRW304P 20 268 MP Pharmaceutics RELEASE, FLOATING, 268 UNIT FLOATING – BIOADHESIVE MINITABLETS YADAV INSITU IR, ODT, DT, SUBLINGUAL, DESIGN, DEVELOPMENT AND CHARACTERIZATION OF 292 22-Nov-19 182680820007 PATEL SARANGKUMAR MANOJBHAI MRW304P 20 268 MP Pharmaceutics FAST DR. DHIREN P SHAH 268 PROMETHAZINE HCL ORODISPERSIBLE TABLET DISPERSIBLE/DISSOLVI IR, ODT, DT, SUBLINGUAL, DESIGN,DEVELOPMENT AND CHARACTERIZATION OF FAST 293 22-Nov-19 182680820008 PATEL SEJALKUMARI BABUBHAI MRW304P 20 268 MP Pharmaceutics FAST MR. TEJAS J PATEL 268 DISSOLVING ORAL FILM OF HALOPERIDOL. DISPERSIBLE/DISSOLVI Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL SIMULTENEOUS 294 22-Nov-19 182740824001 KARDANI MONALIBEN DILIPBHAI MRW304P 24 274 MP Quality METHODS FOR NEPAFENAC AND DEXAMETHASONE IN DR. H A RAJ 274 ESTIMATION Assurance COMBINATION Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL SIMULTENEOUS 295 22-Nov-19 182740824002 KUSHWAHA RAMPYARI RAMGOPAL MRW304P 24 274 MP Quality METHODS FOR PARACETAMOL, IBUPROFEN AND DR. H A RAJ 274 ESTIMATION Assurance DEXAMETHASONE IN COMBINATION Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL SIMULTENEOUS 296 22-Nov-19 182740824004 Rawal Sneha Kishorkumar MRW304P 24 274 MP Quality METHODS FOR MOXIFLOXACIN AND CLOTRIMAZOLE IN DR. H A RAJ 274 ESTIMATION Assurance COMBINATION

Page 17 MEDICINAL DESIGN, SYNTHESIS AND PANCREATIC LIPASE INHIBITORY Pharmaceutical 297 25-Nov-19 182020822002 Patel Khushboo Hiteshbhai MRW304P 22 202 MP OTHER (KINDLY SPECIFY) CHEMISTRY (ANTI ACTIVITY OF NOVEL QUINAZOLINE DERIVATIVES AS ANTI- DR. VIPUL M. VAGHELA 202 Chemistry OBESITY AGENTS) OBESITY AGENTS

MEDICINAL Pharmaceutical CHEMISTRY (ANTI SYNTHESIS AND SCREENING OF BENZIMIDAZOLE 298 25-Nov-19 182020822001 KAPUPARA CHARVI ASHOKBHAI MRW304P 22 202 MP OTHER (KINDLY SPECIFY) DR. DINESH V. THAKKAR 202 Chemistry TUBERCULAR DERIVATIVES AS ANTI TUBERCULAR AGENTS AGENTS)

SYSTEMATIC SCRUTINISATION OF VITAL FACTORS FOR CO PROCESSED, DC, DEVELOPING FORMULATION OF MODEL POORLY SOLUBLE Pharmaceutical 299 25-Nov-19 182050828002 Nisha Choudhary MRW304P 28 205 MP TABLET/CAPSULE DRUG VIA MOISTURE ACTIVATED DRY GRANULATION MS. DIPIKA CHAVDA 205 Technology EXCIPIENTS AND AT TECHNOLOGY: AN EFFORT TO DEMONSTRATE THE USE OF LEAN DRUG MANUFACTURING DEVELOPMENT OF SUPERDISINTEGRATING IMMEDIATE Pharmaceutical 300 25-Nov-19 182050828001 Asmita MRW304P 28 205 MP MULTIPARTICULATE RELEASE FEBUXOSTAT PELLETS BY INCORPORATING NOVEL DR. MUKESH C. GOHEL 205 Technology EXCIPIENTS NOVEL Pharmaceutical NOVEL TECHNIQUE FOR PREPARING METFORMIN BILAYER 301 25-Nov-19 182050828003 SANDEEP SATISHBHAI AGRAWAL MRW304P 28 205 MP OTHER (KINDLY SPECIFY) COMPRESSION DR. MUKESH C. GOHEL 205 Technology TABLET TECHNOLOGY STUDIES IN FORMULATION AND EVALUATION OF 302 25-Nov-19 182120820001 AHIR TEJASKUMAR ASHOKBHAI MRW304P 20 212 MP Pharmaceutics OTHER (KINDLY SPECIFY) COCRYSTALS TADALAFIL COCRYSTAL TO IMPROVE DISSOLUTION DR. JAYANT R. CHAVDA 212 CHARACTERISTICS CO PROCESSED, DC, FORMULATION AND EVALUATION OF AMOXICILLIN DR.CHETAN H. 303 25-Nov-19 182120820003 CHAUHAN HARDIK ALPESHBHAI MRW304P 20 212 MP Pharmaceutics TABLET/CAPSULE 212 TRIHYDRATE SOLID DISPERSION BY SPRAY DRYING BORKHATARIA EXCIPIENTS AND AT CO PROCESSED, DC, ENHANCEMENT OF SOLUBILITY AND IMPROVEMENT OF 304 25-Nov-19 182120820006 KALASARIYA SANJAYKUMAR NATHABHAI MRW304P 20 212 MP Pharmaceutics TABLET/CAPSULE PHYSICOCHEMICAL PROPERTIES BY FORMULATING SPRAY DR.M. M. SONIWALA 212 EXCIPIENTS AND AT DRIED SOLID DISPRSION OF DARUNAVIR ETHANOLATE CO PROCESSED, DC, AUGMENTATION OF PHYSICOCHEMICAL PROPERTIES OF 305 25-Nov-19 182120820007 MIR DEVALBEN BHANABHAI MRW304P 20 212 MP Pharmaceutics TABLET/CAPSULE DR.M. M. SONIWALA 212 ETORICOXIB BY SPHERICAL AGGLOMERATION EXCIPIENTS AND AT NANO FORMULATION AND EVALUATION OF SOLID SELF MICRO 306 25-Nov-19 182120820002 BHALODIA KULDEEP KANTILAL MRW304P 20 212 MP Pharmaceutics SUSPENSION/EMULSION, MR. KALPESH A. PATEL 212 EMULSIFYING DRUG DELIVERY SYSTEM OF DASATINIB SEDDS, LIPID BASED DDS DESIGN, DEVELOPMENT AND OPTIMIZATION OF 307 25-Nov-19 182120820009 PATEL HEMAKSHIBEN DHIRAJLAL MRW304P 20 212 MP Pharmaceutics MULTIPARTICULATE PALIPERIDONE LOADED CHITOSAN NANOPARTICLES FOR DR. SUNNY R. SHAH 212 INTRANASAL DELIVERY FORMULATION AND EVALUATION OF DOSAGE FORM 308 25-Nov-19 182120820010 PATEL PARTHKUMAR HASMUKHBHAI MRW304P 20 212 MP Pharmaceutics MULTIPARTICULATE DR.JAYDEEP.M.PATEL 212 CONTAINING PELLETS FOR ANTIPSYCHOTIC THERAPY STUDY OF INVITRO MODULATORY EFFECT OF PH ON SOLUBILITY 309 25-Nov-19 182120820004 GANGANI USHABEN RAMESHBHAI MRW304P 20 212 MP Pharmaceutics OTHER (KINDLY SPECIFY) HYDROXYPROPYL BETA CYCLODEXTRIN COMPLEX OF DR. JAYANT R. CHAVDA 212 ENHANCEMENT POORLY SOLUBLE DRUG NANO FORMULATION DEVELOPMENT AND EVALUATION OF 310 25-Nov-19 182120820005 GOSAI SHIVANGPARI MAHESHPARI MRW304P 20 212 MP Pharmaceutics SUSPENSION/EMULSION, CARVEDILOL DRY EMULSION USING SPRAY DRYING DR. DIPEN R. BHIMANI 212 SEDDS, LIPID BASED DDS TECHNIQUE

DISSOLUTION ENHANCEMENT OF DISSOLUTION PROPERTIES OF 311 25-Nov-19 182120820011 RANPARIYA FENIL MANSUKHBHAI MRW304P 20 212 MP Pharmaceutics OTHER (KINDLY SPECIFY) DR. RAMESH D. PARMAR 212 ENHANCEMENT CANDESARTAN CILEXETIL USING LIQUISOLID TECHNIQUE CO PROCESSED, DC, FORMULATION,OPTIMIZATION AND EVALUATION OF 312 25-Nov-19 182120820012 SAKRIYA EKTA BHOLABHAI MRW304P 20 212 MP Pharmaceutics TABLET/CAPSULE MR. DHAVAL D. MORI 212 AMORPHOUS SOLID DISPERSION OF CEFPODOXIME AXETIL EXCIPIENTS AND AT IR, ODT, DT, SUBLINGUAL, FORMULATION AND EVALUATION OF BUCCAL FILM OF 313 25-Nov-19 182120820013 Thoriya jay chandreshkumar MRW304P 20 212 MP Pharmaceutics FAST DR. JALPA S. PAUN 212 REPAGLINIDE DISPERSIBLE/DISSOLVI Pharmaceutical RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR 314 25-Nov-19 182120824005 PANDEY MEENAKSHI MANISHANKAR MRW304P 24 212 MP Quality STABILITY STUDIES ESTIMATION OF ACOTIAMIDE HYDROCHLORIDE DR AMITKUMAR J. VYAS 212 Assurance TRIHYDRATE AND ITS RELATED SUBSTANCE

Page 18 Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 315 25-Nov-19 182120824003 JADAV HINABEN MENANDBHAI MRW304P 24 212 MP Quality STABILITY STUDIES INDICATING METHOD FOR SIMULTANEOUS ESTIMATION DR. ASHOK B. PATEL 212 Assurance OF ATORVASTATIN CALCIUM AND VITAMIN D3 BY RP-HPLC

Pharmaceutical DEVELOPMENT AND VALIDATION OF STATBILITY 316 25-Nov-19 182120824007 PATEL DHRUTI MAHESHKUMAR MRW304P 24 212 MP Quality STABILITY STUDIES INDICATING ASSAY AND RELATED SUBSTANCE SUBSTANCE DR. NILESH K. PATEL 212 Assurance OF CARIPRAZINE HYDROCHLORIDE BY HPLC BIOANALYTICAL METHOD DEVELOPMENT AND Pharmaceutical VALIDATION FOR ESTIMATION OF NITROGLYCERIN AND ITS 317 25-Nov-19 182120824014 VAGHASIYA EKTA HARSUKHBHAI MRW304P 24 212 MP Quality BIOANALYTICAL DR. ASHOK B. PATEL 212 METABOLITES IN K3EDTA HUMAN PLASMA BY USING LC- Assurance ESI-MS/MS STABILITY INDICATING ANALYTICAL METHOD Pharmaceutical DEVELOPMENT AND VALIDATION FOR FIMASARTAN 318 25-Nov-19 182120824008 PATEL MAHINKUMAR PARESHBHAI MRW304P 24 212 MP Quality STABILITY STUDIES DR. NILESH K. PATEL 212 POTASSIUM TRIHYDRATE AND ITS RELATED SUBSTANCES Assurance BY HPLC STABILITY INDICATING METHOD DEVELOPMENT AND Pharmaceutical VALIDATION FOR SIMULTANEOUS ESTIMATION OF 319 25-Nov-19 182120824011 RANA BHUMIKA HARISHBHAI MRW304P 24 212 MP Quality STABILITY STUDIES DR. NILESH K. PATEL 212 RABEPRAZOLE SODIUM AND MOSAPRIDE CITRATE IN Assurance TABLET DOSAGE FORM BY UPLC STABILITY INDICATING ANALYTICAL METHOD Pharmaceutical DEVELOPMENT AND VALIDATION FOR ESTIMATION OF 320 25-Nov-19 182120824013 SHWETA GOSAI MRW304P 24 212 MP Quality SOLUBILITY STUDIES DR. AJAY I. PATEL 212 ELTROMBOPAG OLAMINE AND ITS RELATED SUBSTANCE Assurance BY HPLC STABILITY INDICATING METHOD DEVELOPMENT AND Pharmaceutical VALIDATION FOR SIMULTANEOUS ESTIMATION OF 321 25-Nov-19 182120824006 PATEL ASTHA JAMANBHAI MRW304P 24 212 MP Quality IMPURITY PROFILING DEXTROMETHORPHAN HYDROBROMIDE AND DR. NILESH K. PATEL 212 Assurance CHLORPHENIRAMINE MALEAT IN TABLET DOSAGE FORM BY UPLC DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD Pharmaceutical FOR ESTIMATION OF GENOTOXIC IMPURITIES IN HYDROXY 322 25-Nov-19 182120824009 PRAJAPATI KRUPA BABUBHAI MRW304P 24 212 MP Quality IMPURITY PROFILING DR. AJAY I. PATEL 212 CHLOROQUINE SULFATE DRUG SUBSTANCE BY Assurance CHROMATOGRAPHY Pharmaceutical BIOANALYTICAL METHOD DEVELOPMENT AND 323 25-Nov-19 182120824004 KishnaRam MRW304P 24 212 MP Quality BABE VALIDATION FOR ESTIMATION OF PHENYTOIN IN K3EDTA DR. AJAY I. PATEL 212 Assurance HUMAN PLASMA BY USING LC-ESI-MS/MS Pharmaceutical ANALYTICAL METHOD DEVELOPMENT AND VALIDATION SIMULTENEOUS 324 25-Nov-19 182120824001 GOL DHRUVANSHIBEN ASHOKKUMAR MRW304P 24 212 MP Quality FOR SIMULTANEOUS ESTIMATION OF TADALAFIL AND DR. AMITKUMAR J. VYAS 212 ESTIMATION Assurance MACITENTAN IN SYNTHETIC MIXTURE USING RP-HPLC

Pharmaceutical RP-HPLC METHOD DEVELOPMENT AND ITS VALIDATION SIMULTENEOUS 325 25-Nov-19 182120824012 RAVAL DISHABEN HIMANSHUKUMAR MRW304P 24 212 MP Quality FOR SIMULTANEOUS ESTIMATION OF ROSUVASTATIN DR. AMITKUMAR J. VYAS 212 ESTIMATION Assurance CALCIUM AND VITAMIN D3 IN TABLET DOSAGE FORM.

Pharmaceutical RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTENEOUS 326 25-Nov-19 182120824010 RAHULKUMAR LAKHABHAI MAKWANA MRW304P 24 212 MP Quality SIMULTANEOUS ESTIMATION OF RANOLAZINE AND DR. ASHOK B. PATEL 212 ESTIMATION Assurance METFORMIN HYDROCHLORIDE IN SYNTHETIC MIXTURE

Pharmaceutical STABILITY INDICATING HPTLC METHOD DEVELOPMENT 327 25-Nov-19 182150824003 THAKKAR HIREN GHANSHYAMBHAI MRW304P 24 215 MP Quality STABILITY STUDIES AND VALIDATION OF CLOMIPRAMINE HYDROCHLORIDE IN DR. ZARNA DEDANIA 215 Assurance PHARMACEUTICAL DOSAGE FORM STABILITY INDICATING HPLC METHOD DEVELOPMENT AND Pharmaceutical VALIDATION FOR ITRACONAZOLE AND TERBINAFINE 328 25-Nov-19 182150824004 THUTAN SHWETABEN KAVDUBHAI MRW304P 24 215 MP Quality STABILITY STUDIES DR. ZARNA DEDANIA 215 HYDROCHLORIDE IN COMBINED PHARMACEUTICAL Assurance DOSAGE FORM Pharmaceutical DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR SIMULTENEOUS 329 25-Nov-19 182150824002 NISAD SAPNAKUMARI RAMRATAN MRW304P 24 215 MP Quality DETERMINATION OF ZONISAMIDE AND CILOSTAZOL IN DR. ZARNA DEDANIA 215 ESTIMATION Assurance SYNTHETIC MIXTURE Pharmaceutical DEVELOPMENT AND VALIDATION OF ANALYTICAL SIMULTENEOUS DR. GHANSHYAM 330 25-Nov-19 182150824001 DIXIT ANMOL RAJENDRAPRASAD MRW304P 24 215 MP Quality METHODS FOR SIMULTANEOUS ESTIMATION OF 215 ESTIMATION SHANGHANI Assurance FLUCONAZOLE AND ZINC PYRITHIONE IN LOTION

Page 19 MEDICINAL Pharmaceutical DESIGN AND SYNTHESIS OF INDOLE-2-CARBOXAMIDES AS 331 25-Nov-19 182280822005 VAGHELA PUNIT VIJAYBHAI MRW304P 22 228 MP OTHER (KINDLY SPECIFY) CHEMISTRY-ANTI- DR. TEJAS M. DHAMELIYA 228 Chemistry POTENTIAL ANTI-TB AGENTS TB AGENTS MEDICINAL DESIGN, SYNTHESIS AND EVALUATION OF SOME Pharmaceutical CHEMISTRY- PROF. MAHESH T. 332 25-Nov-19 182280822003 PATEL KISHAN RAMESHBHAI MRW304P 22 228 MP OTHER (KINDLY SPECIFY) THIAZOLOPYRIMIDINE DERIVATIVE AS ANTIFUNGAL 228 Chemistry ANTIFUNGAL CHHABRIA AGENTS AGENTS Pharmaceutical DESIGN AND SYNTHESIS OF SOME NOVEL 1,3,4- 333 25-Nov-19 182280822001 JADEJA SHWETABA BALBHADRASINH MRW304P 22 228 MP OTHER (KINDLY SPECIFY) ANTI-TB AGENTS DR. DIPEN SUREJA 228 Chemistry OXADIAZOLE ANALOGUES AS ANTI-TUBERCULAR AGENTS RESPIRATORY DISORDER ( EVALUTION OF ANTI FIBROTIC EFFECT OF OMEPRAZOLE 334 26-Nov-19 182280825006 PATEL VISHWABEN MUKESHBHAI MRW304P 25 228 MP Pharmacology PLEASE SPECIFY DISORDER AND D- PENICILLAMINE IN BLEOMYCIN INDUCED LUNG DR. GAURANG B. SHAH 228 OR FIBROSIS IN MICE DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF Pharmaceutical MEDICINAL CHEMISTRY PROF. ANURADHA K. 335 25-Nov-19 182280822004 Pradhan Sanmey vikasbhai MRW304P 22 228 MP DERIVATIVES OF 2-AMINO THIOPHENE AS ANTI-DIABETIC 228 Chemistry (ANTIDIABETICS) GAJJAR AGENTS BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF BIFOCONAZOLE IN 336 25-Nov-19 182310820002 MAKADIA RAVINABEN HAMIRBHAI MRW304P 20 231 MP Pharmaceutics TDDS, TOPICAL, DR. SANDIP PATEL 231 SITU GEL FOR THRUSH HYDROGELS NASAL SOLUBILITY SOLUBILITY ENHANCEMENT OF BCS CLASS II DRUG USING 337 25-Nov-19 182310820003 MAKAVANA DHAVAL NARANBHAI MRW304P 20 231 MP Pharmaceutics OTHER (KINDLY SPECIFY) MR. SUMIT CHAKRABORTY 231 ENHNCEMENT SOLID DISPERSION TECHNIQUE Pharmaceutical DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD METHOD 338 25-Nov-19 182420824005 PATEL RUCHITA RAJUBHAI MRW304P 24 242 MP Quality OTHER (KINDLY SPECIFY) FOR ESTIMATION OF LURASIDONE AND ITS IMPURITIES DR. ANKIT B. CHAUDHARY 242 DEVELOPMENT Assurance LURASIDONE 1 AND LURASIDONE 8 Pharmaceutical COMPARATIVE STUDY OF QBD IMPLEMENTATION 339 25-Nov-19 182420824001 Bhayani Mital Arvindbhai MRW304P 24 242 MP Quality OTHER (KINDLY SPECIFY) QBD CONCEPT DR. ANKIT B. CHAUDHARY 242 PERSPECTIVE IN USA, EUROPE, JAPAN AND INDIA Assurance Pharmaceutical DEVELOPMENT & VALIDATION OF RP-HPLC METHOD FOR METHOD 340 25-Nov-19 182420824002 DHARSANDIYA NIDHIBEN JENTILAL MRW304P 24 242 MP Quality OTHER (KINDLY SPECIFY) ESTIMATION OF TENELIGLIPTIN AND ITS IMPURITIES IN DR. ANKIT B. CHAUDHARY 242 DEVELOPMENT Assurance TABLET Pharmaceutical DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD METHOD 341 25-Nov-19 182420824004 Patel Chiragkumar Kamleshkumar MRW304P 24 242 MP Quality OTHER (KINDLY SPECIFY) FOR ESTIMATION OF DAPAGLIFLOZIN AND ITS IMPURITIES DR. NAVNEET F. CHAUHAN 242 DEVELOPMENT Assurance DAPAGLIFLOZIN 3 AND DAPAGLIFLOZIN 37 Pharmaceutical COMPARATIVE STUDY OF REGULATORY GUIDELINE OF 342 25-Nov-19 182420824003 MODI BIJAL JAYANTILAL MRW304P 24 242 MP Quality REGULATORY AFFAIRS MS. JIGNA T. PATEL 242 BIOWAIVERS IN DIFFERENT REGULATORY MARKET Assurance Pharmaceutical STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT 343 25-Nov-19 182420824006 THAKAR RUCHIBEN ANILKUMAR MRW304P 24 242 MP Quality STABILITY STUDIES AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MS. CHARMY D. PANDYA 242 Assurance DOLUTEGRAVIR AND LAMIVUDINE IN TABLET BUCO/MUCOADHESIVE, FORMULATION AND EVALUATION OF MEDICATED NAIL 344 25-Nov-19 182510820001 PATHAN SURAIYA ASHRAFKHAN MRW304P 20 251 MP Pharmaceutics TDDS, TOPICAL, DR. TUSHAR A. GOHIL 251 LACQUER OF SERTACONAZOLE NITRATE HYDROGELS NASAL DELAYED/EXTENDED FORMULATION AND EVALUATION OF COLON TARGETED 345 25-Nov-19 182510820002 SARVAIYA DIPASVIBEN DALPATBHAI MRW304P 20 251 MP Pharmaceutics RELEASE, FLOATING, DR. TUSHAR A. GOHIL 251 MINI TABLETS OF ORNIDAZOLE INSITU Pharmaceutical MEDICINAL CHEMISTRY SYNTHESIS OF NEW THIAZOLE DERIVATIVES AS 346 25-Nov-19 182540822002 patel salman ismail MRW304P 22 254 MP DR. M. N. NOOLVI 254 Chemistry (ANTICANCER) ANTICANCER AGENTS Pharmaceutical MEDICINAL CHEMISTRY SYNTHESIS OF NEW DIAMINO PYRIMIDINE DERIVATIVES AS 347 25-Nov-19 182540822001 MIRZA SOHANABIBI RAFIK MRW304P 22 254 MP DR. M. N. NOOLVI 254 Chemistry (ANTICANCER) ANTICANCER AGENTS Pharmaceutical ANTI-ALZHEIMER SYNTHESIS OF NEW FLAVONOL DERIVATIVES AS ANTI- 348 25-Nov-19 182540822003 RANA MAHIRAKHATUN RANJITSINH MRW304P 22 254 MP OTHER (KINDLY SPECIFY) DR. MORE UTTAM 254 Chemistry AGENTS ALZHEIMER AGENTS Pharmaceutical ANTI-TUBERCULAR SYNTHESIS OF NEW DIPHENYL ETHER DERIVATIVES AS 349 25-Nov-19 182540822004 Vaja Mukesh MRW304P 22 254 MP OTHER (KINDLY SPECIFY) DR. MORE UTTAM 254 Chemistry AGENTS ANTI-TUBERCULAR AGENTS

FORMULATION DEVELOPMENT FOR OPTIMIZING DELIVERY BIOAVAILABILITY 350 25-Nov-19 182610820001 DAXINI KAPILKUMAR VINODBHAI MRW304P 20 261 MP Pharmaceutics OTHER (KINDLY SPECIFY) OF POORLY BIOAVAILABLE DRUG BASED ON MODULATION DR.JIGAR VYAS 261 ENHANCEMENT OF THE ROLE OF PGP EFFLUX PUMP SOLUBILITY FORMULATION AND DEVELOPMENT OF LIQUISOLID 351 25-Nov-19 182610820002 PATEL JUHIBEN HARIKRUSHNABHAI MRW304P 20 261 MP Pharmaceutics OTHER (KINDLY SPECIFY) DR.JITENDRA PATEL 261 ENHANCEMENT TABLET OF POORLY SOLUBLE DRUG

Page 20 FORMULATION AND DEVELOPMENT OF LULICONAZOLE 352 25-Nov-19 182610820003 PATEL RIA NITINBHAI MRW304P 20 261 MP Pharmaceutics MULTIPARTICULATE MICROSPONGES FOR TOPICAL DELIVERY SYSTEM USING DR.CHAINESH SHAH 261 QBD APPROACH Pharmaceutical DISSOLUTION METHOD DEVELOPMENT AND VALIDATION 353 25-Nov-19 182610824002 Solanki Jaydipsinh Manharsinh MRW304P 24 261 MP Quality DISSOLUTION STUDIES OF THE METFORMIN HYDROCHLORIDE(SR) AND MRS.PUJA VYAS 261 Assurance TENELIGLIPTIN IN COMBINED DOSAGE FORM BY RP-HPLC DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING RP-HPLC METHOD FOR SIMULTANEOUS 354 25-Nov-19 182690824005 MINIYA PRIYANKABEN PARESHBHAI MRW304P 24 269 MP Quality STABILITY STUDIES DR SIBAJI SARKAR 269 ESTIMATION OF MIFEPRISTONE AND MISOPROSTOL IN ITS Assurance ORAL SOLID DOSAGE FORM DEVELOPMENT AND VALIDATION OF STABILITY- Pharmaceutical INDICATING RP-HPLC METHOD FOR THE ESTIMATION OF 355 25-Nov-19 182690824009 VADGAMA TEJAS RAMNIKLAL MRW304P 24 269 MP Quality IMPURITY PROFILING DR SIBAJI SARKAR 269 BEXAROTENE AND ITS IMPURITIES IN ORAL SOLID DOSAGE Assurance FORM DEVELOPMENT AND VALIDATION OF A STABILITY- Pharmaceutical INDICATING RP-HPLC METHOD FOR ESTIMATION OF 356 25-Nov-19 182690824002 GAJERA BINAL ASHOKBHAI MRW304P 24 269 MP Quality IMPURITY PROFILING SODIUM VALPROATE AND VALPROIC ACID ALONG WITH DR SIBAJI SARKAR 269 Assurance IMPURITIES FROM A COMBINED ORAL SOLID DOSAGE FORM DEVELOPMENT AND VALIDATION OF A STABILITY- Pharmaceutical SIMULTENEOUS INDICATING METHOD FOR THE SIMULTANEOUS 357 25-Nov-19 182690824008 THESIYA SWATIBEN DHEERUBHAI MRW304P 24 269 MP Quality D.K TARAI 269 ESTIMATION ESTIMATION OF AMBROXOL AND DOXYCYCLINE USING Assurance THE RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD Pharmaceutical SIMULTENEOUS FOR SIMULTANEOUS ESTIMATION OF MIFEPRISTONE AND 358 25-Nov-19 182690824006 PAL ARCHANA HARIRAM MRW304P 24 269 MP Quality KOMAL R. DHUDASHIA 269 ESTIMATION MISOPROSTOL IN IT’S COMBINED PHARMACEUTICAL Assurance DOSAGE FORM. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION Pharmaceutical SIMULTENEOUS FOR SIMULTANEOUS ESTIMATION OF CILNIDIPINE AND 359 25-Nov-19 182690824003 KALOLA NENSI AMRUTLAL MRW304P 24 269 MP Quality KOMAL R. DHUDASHIA 269 ESTIMATION PROPRANOLOL IN COMBINED DOSAGE FORM BY USING RP- Assurance HPLC METHOD. Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 360 25-Nov-19 182690824001 Faldu Jay Maganlal MRW304P 24 269 MP Quality IMPURITY PROFILING INDICATING RP-HPLC METHOD FOR LURASIDONE AND ITS D.K TARAI 269 Assurance IMPURITIES IN PHARMACEUTICAL DOSAGE FORM

Pharmaceutical DEVELOPMENT AND VALIDATION OF STABILITY 361 25-Nov-19 182690824007 SOLANKI HINALBEN KISHORBHAI MRW304P 24 269 MP Quality IMPURITY PROFILING INDICATING RP-HPLC METHOD FOR VORTIOXETINE AND D.K TARAI 269 Assurance ITS IMPURITIES IN PHARMACEUTICAL DOSAGE FORM RELATED Pharmaceutical DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD IMPURITIES (IN- 362 25-Nov-19 182690824004 Kanetiya Mansiben Mukeshbhai MRW304P 24 269 MP Quality OTHER (KINDLY SPECIFY) FOR THE ESTIMATION OF TERIFLUNOMIDE AND ITS KOMAL R. DHUDASHIA 269 PROCESS Assurance RELATED IMPURITIES IN IT’S ORAL SOLID DOSAGE FORM. IMPURITIES) Pharmaceutical STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT 363 25-Nov-19 182820824002 BANGIYA MINHAJ IKBAL MRW304P 24 282 MP Quality PROCESS VALIDATION AND VALIDATION FOR ESTIMATION OF BEPOTASTINE DR. M.B.SHANKAR 282 Assurance HYDROCHLORIDE IN ITS BULK DEVELOPMENT AND VALIDATION OF STABILITY Pharmaceutical INDICATING ASSAY METHOD FOR ATAZANUVIR SULPHATE 364 25-Nov-19 182820824003 Thavrani Kajal Paresh MRW304P 24 282 MP Quality PROCESS VALIDATION DR. M.B.SHANKAR 282 IN BULK DRUG AND CAPSULE DOSAGE FORM AND ITS Assurance APPLICATION IN DISSOLUTION BY RP-HPLC. EVALUATION OF NLRP3 INFLAMMASOME INHIBITOR IN 365 26-Nov-19 182050825003 CHANDEL ATULSINGH JAYNARAYANSINGH MRW304P 25 205 MP Pharmacology CVS DISORDER EXPERIMENTALLY INDUCED CARDIAC FIBROSIS IN DR. TEJAL GANDHI 205 UNINEPHRECTOMIZED RATS EVALUATION OF PROTECTIVE EFFECT OF SNAIL-1 366 26-Nov-19 182050825004 GAJERA HARSHKUMAR BHARATBHAI MRW304P 25 205 MP Pharmacology CVS DISORDER DR. TEJAL GANDHI 205 INHIBITOR IN CARDIAC FIBROSIS IN EXPERIMENTAL RATS

EVALUATION OF ANTHRAQUINONE RICH FRACTION OF 367 26-Nov-19 182050825005 KAZI ASFIYA JAVIDALI MRW304P 25 205 MP Pharmacology CVS DISORDER DR. SARIKA JOHARI 205 RHUBARB IN CARDIAC FIBROSIS IN EXPERIMENTAL RATS

Page 21 EVALUATION OF CARDIOPROTECTIVE EFFECT OF 368 26-Nov-19 182050825007 RANA KHYATI MUKESHBHAI MRW304P 25 205 MP Pharmacology CVS DISORDER RANOLAZINE IN HIGH FAT DIET AND STREPTOZOTOCIN DR. TEJAL GANDHI 205 INDUCED DIABETIC CARDIOMYOPATHY

STUDY OF CARDIOPROTECTIVE EFFECT OF PRASUGREL IN 369 26-Nov-19 182050825008 SAIYED FALAKAARA HASHMATALI MRW304P 25 205 MP Pharmacology CVS DISORDER DR. TEJAL GANDHI 205 MYOCARDIAL ISCHEMIA/REPERFUSION INJURY

EFFECT OF PPAR ?/G DUAL AGONIST IN STREPTOZOTOCIN 370 26-Nov-19 182050825010 Thakkar Brijesh Jayendra MRW304P 25 205 MP Pharmacology CVS DISORDER DR. TEJAL GANDHI 205 INDUCED DIABETIC CARDIOMYOPATHY IN RATS EVALUATION OF ANTI-UROLITHIATIC EFFECT OF HERBAL 371 26-Nov-19 182050825002 Chanchal Yadav MRW304P 25 205 MP Pharmacology RENAL DISORDERS DR. TEJAL GANDHI 205 FORMULATIONS IN EXPERIMENTAL RATS EFFECT OF SAPONIN AND FLAVONOID RICH EXTRACTS OF 372 26-Nov-19 182050825009 SANCHANIYA DIVYA ARVINDBHAI MRW304P 25 205 MP Pharmacology RENAL DISORDERS BRYOPHYLLUM PINNATUM ON CRYSTAL DEPOSITION IN DR. TEJAL GANDHI 205 EXPERIMENTAL UROLITHIASIS SYSTEMATIC TOXICOLOGICAL EVALUATION OF NATURAL 373 26-Nov-19 182050825001 AGHERA CHIRAGKUMAR RASIKLAL MRW304P 25 205 MP Pharmacology TOXICITY STUDY DR. SARIKA JOHARI 205 FLAVONOID QUERCETIN IN RODENTS EVALUATION OF ANTI-ARTHRITIC ACTIVITY OF IMMUNO- 374 26-Nov-19 182120825003 KRITIKA RAINA MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY) PETROSELINUM CRISPUM LEAVES EXTRACT BY FREUNDS DR. RAVI A. MANEK 212 INFLAMMATORY ADJUVANT INDUCED ARTHRITIS IN RATS EVALUATION OF IMMUNOMODULATORY AND ANTI- IMMUNO 375 26-Nov-19 182120825004 MAJITHIA BRINDA RAJESHBHAI MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY) INFLAMMATORY ACTIVITY OF POLYHERBAL FORMULATION DR. RAVI A. MANEK 212 MODULATORY` BY EXPERIMENTAL ANIMAL MODELS IN RATS

EVALUATION OF EFFECT OF ETHANOLIC EXTRACT OF IMMUNO- 376 26-Nov-19 182120825007 PATEL VRUTTI THAKORBHAI MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY) FAGONIA CRETICA L. PLANT AGAINST EXPERIMENTALLY DR. DEVANG B. SHETH 212 INFLAMMATORY INDUCED ULCERATIVE COLITIS IN RATS EVALUATION OF EFFECT OF METHANOLIC EXTRACT OF IMMUNO- 377 26-Nov-19 182120825008 sorathiya kirti dineshbhai MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY) MEDICAGO SATIVA L. SPROUTS ON CHEMICAL INDUCED DR. JIGNESH I. PATEL 212 INFLAMMATORY ULCERATIVE COLITIS IN RATS METABOLIC DISORDER ( ASSESSMENT OF DIABETIC WOUND HEALING POTENTIAL 378 26-Nov-19 182120825001 KANABAR KRINA BHUPATBHAI MRW304P 25 212 MP Pharmacology PLEASE SPECIFY OF AZADIRACHTA INDICA LEAVES EXTRACT USING IN- DR. DEVANG B. SHETH 212 DISORDER) VITRO AND IN-VIVO ASSAYS METABOLIC DISORDER ( EVALUATION OF ANTI-DIABETIC ACTIVITY OF POLYHERBAL 379 26-Nov-19 182120825002 KHILJI RUKHSHAR BANU MRW304P 25 212 MP Pharmacology PLEASE SPECIFY FORMULATION IN EXPERIMENTALLY INDUCED DIABETES IN DR. RAVI A. MANEK 212 DISORDER) RATS BIOEQUIVALENCE STUDY OF SAXAGLIPTIN 2.5 MG AND 380 26-Nov-19 182130825001 DHAMANE DIVYANSHI AVINASH MRW304P 25 213 MP Pharmacology BABE STUDY METFORMIN 1000 MG FILM COATED TABLETS IN FED DR. DIGVIJAYSINH G. RANA 213 CONDITIONS GHODASARA DENISHKUMAR BIOEQUIVALENCE STUDY OF FEBUXOSTAT FILM COATED 381 26-Nov-19 182130825002 MRW304P 25 213 MP Pharmacology BABE STUDY DR. DIGVIJAYSINH G. RANA 213 DINESHKUMAR TABLETS 80 MG IN FASTING CONDITIONS REPRODUCTIVE A RETROSPECTIVE STUDY OF DRUG UTILIZATION IN 382 26-Nov-19 182130825003 sardhara shivani rajendrakumar MRW304P 25 213 MP Pharmacology OTHER (KINDLY SPECIFY) DR. DEEPTI K. JANI 213 DISEASES GYNAECOLOGICAL INFECTIONS Pharmaceutical A STUDY ON REGULATORY REQUIREMENT FOR 383 26-Nov-19 182150827001 DESAI GRISHMABEN KETANBHAI MRW304P 27 215 MP Regulatory REGULATORY AFFAIRS REGISTRATION OF SIROLIMUS ELUTING CORONARY STENT DR. RONAK DEDANIA 215 Affairs IN INDIA, EU AND TAIWAN Pharmaceutical CURRENT STATUS OF GENERIC DRUG APPROVAL PROCESS 384 26-Nov-19 182150827002 PANDEY JYOTI GORAKHNATH MRW304P 27 215 MP Regulatory REGULATORY AFFAIRS DR. RONAK DEDANIA 215 IN INDIA AND CANADA Affairs DOSSIER SUBMISSION OF DRUG CONTAINING Pharmaceutical ROSUVASTATIN TABLET AS PER REGISTRATION GUIDELINES 385 26-Nov-19 182150827008 SINGH SHOBHA SATENDRA MRW304P 27 215 MP Regulatory REGULATORY AFFAIRS DR. VINEET JAIN 215 OF RUSSIA AND COMPARE RUSSIAN GUIDELINES WITH Affairs EUROPEAN GUIDELINES Pharmaceutical DOSSIER PREPARATION OF DRUG CONTAINING 386 26-Nov-19 182150827009 VANI NAMRATA SURESHCHANDRA MRW304P 27 215 MP Regulatory REGULATORY AFFAIRS CLARITHROMYCIN TABLET AS PER GUIDELINE IN UGANDA DR. RONAK DEDANIA 215 Affairs AND IT’S COMPARISON WITH INDIA Pharmaceutical TO PREPARE A DOSSIER CONTAINING LEVOFLOXACIN 387 26-Nov-19 182150827004 PATEL NILIMA DHIRUBHAI MRW304P 27 215 MP Regulatory REGULATORY AFFAIRS TABLET FOR REGISTRATION IN MYANMAR AND IT’S DR. VINEET JAIN 215 Affairs COMPARISON WITH USA

Page 22 Pharmaceutical REGULATORY REQUIREMENT FOR DOSSIER SUBMISSION 388 26-Nov-19 182150827006 SHAH KINJAL VINAY MRW304P 27 215 MP Regulatory REGULATORY AFFAIRS FOR DICLOFENAC POTASSIUM AND LOPERAMIDE IN DR. RONAK DEDANIA 215 Affairs NIGERIA Pharmaceutical CURRENT REGULATORY REQUIREMENT FOR 389 26-Nov-19 182150827007 SHIRSATH ARCHANA SATISH MRW304P 27 215 MP Regulatory REGULATORY AFFAIRS REGISTRATION OF ONCOLOGICAL PRODUCT IN MYANMAR, DR. VINEET JAIN 215 Affairs INDIA AND NEPAL EVALUATION OF DOPAMINE RECEPTOR MODULATORS ON DR. MEHUL R. 390 26-Nov-19 182280825002 HIMIKA HASMUKHBHAI RATHI MRW304P 25 228 MP Pharmacology CNS DISORDER 228 MORPHINE TOLERANCE AND ADDICTION IN MICE CHORAWALA

EVALUATION OF PROTECTIVE EFFECTS OF PHLORIZIN IN 391 26-Nov-19 182280825003 PANCHAL VIDHI NATVARLAL MRW304P 25 228 MP Pharmacology CVS DISORDER DR. ANITA A. MEHTA 228 EXPERIMENTALLY INDUCED MYOCARDIAL I/R INJURY. EVALUATION OF CARDIOPROTECTIVE EFFECTS OF 392 26-Nov-19 182280825007 PUROHIT SWETA HAREH MRW304P 25 228 MP Pharmacology CVS DISORDER DR. ANITA A. MEHTA 228 CILOSTAZOL IN I/R INJURY IN ISOLATED RAT HEART EVALUATION OF CARDIOPROTECTIVE ACTIVITY OF METFORMIN, RESVERATROL AND BERBERINE ALONE AND 393 26-Nov-19 182280825009 Trivedi Mansi Vinod kumar MRW304P 25 228 MP Pharmacology CVS DISORDER DR. GAURANG B. SHAH 228 IN COMBINATION IN ISOPROTERENOL INDUCED HEART FAILURE IN RATS EFFICACY STUDY OF CAMEL MILK AND EPALRESTAT DR. MUSTAKIM M. 394 26-Nov-19 182280825005 Patel Krupa Dineshkumar MRW304P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY) LIVER DISEASE 228 AGAINST HEPATOTOXICITY IN RATS MANSURI AUTO IMMUNE STUDY OF SEROTONINS ROLE IN CFA INDUCED ARTHRITIS DR. MUSTAKIM M. 395 26-Nov-19 182280825008 TRIPATHI ASHUTOSH RAMASHANKER MRW304P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY) 228 DISORDER IN RATS MANSURI COMPARATIVE EFFICACY STUDY OF LIVE AND HEAT KILLED SACCHAROMYCES CEREVISIAE IN COMBINATION WITH 396 26-Nov-19 182280825010 VAGHELA KIRAN BHARATKUMAR MRW304P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY) LIVER DISEASE DR. GAURANG B. SHAH 228 SODIUM SELENATE IN CCL4 INDUCED LIVER FIBROSIS IN RAT EVALUATION OF ANTICANCER MODULATING EFFICAY OF 397 26-Nov-19 182280825001 Chettiar Poojashree Boopathyraj MRW304P 25 228 MP Pharmacology CANCER ACANTHUS ILLICIFOLIUS AND MUSA PARADISIACA ALONG DR. SUNITA GOSWAMI 228 WITH DOCETAXEL ON PROSTATE CANCER CELLS LEAD MODIFICATION STUDIES OF A SERIES OF Pharmaceutical INFECTIOUS 398 25-Nov-19 182280822002 PATEL APEXA NAVNEETBHAI MRW304P 22 228 MP OTHER (KINDLY SPECIFY) PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS POTENTIAL DR. MAHESH T. CHHABRIA 228 Chemistry DISEASE ANTI-MYCOBACTERIAL AGENTS EFFECT OF BAUHINIA PURPUREA BARK EXTRACT AND ANETHUM GRAVEOLENS FRUIT EXTRACT ON 399 26-Nov-19 182390825001 DAVDA BHAKTI KAILESH MRW304P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) PCOS DR. ARINDAM PAUL 239 EXPERIMENTALLY INDUCED POLYCYSTIC OVARY SYNDROME IN RATS EFFECT OF POLYHERBAL FORMULATION AGAINST 400 26-Nov-19 182390825002 JAINEE DAXESH VASHI MRW304P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) BPH EXPERIMENTALLY INDUCED MODELS OF BENIGN MR. MITTAL DALAL 239 PROSTATIC HYPERPLASIA IN RATS PHARMACOLOGICAL EVALUATION OF ANTI- ANTI- HEMORRHOIDAL POTENTIAL OF POLYHERBAL 401 26-Nov-19 182390825007 SALUNKE SNEHAL SHRIKANT MRW304P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) DR. ARINDAM PAUL 239 HEMORRHOID FORMULATIONS AGAINST CROTON OIL INDUCED MODEL IN RATS EFFECT OF DIOSCOREA HISPIDA DENNST. TUBER ON 402 26-Nov-19 182390825009 TANDEL DIVYA JITENDRA MRW304P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) ARTHRITIS EXPERIMENTALLY INDUCED RHEUMATOID ARTHRITIS AND DR. ARINDAM PAUL 239 GOUT IN RATS SUBCHRONIC TOXICITY STUDY OF T-AYU-HM™ PREMIUM : 403 26-Nov-19 182390825004 MAITRI RAJESH KALAN MRW304P 25 239 MP Pharmacology TOXICITY STUDY DR. ANKIT MERAI 239 A HERBOMINERAL FORMULATION G.I. TRACT ( PLEASE EVALUATION OF LAXATIVE EFFECT OF VASULAX - A 404 26-Nov-19 182390825003 Lakhani Ruchita Sahbudin MRW304P 25 239 MP Pharmacology SPECIFY DISORDER OR DR. ARINDAM PAUL 239 POLYHERBAL FORMULATION. DISEASE) G.I. TRACT ( PLEASE CYTOPROTECTIVE EFFECT OF IN-SITU GEL CONTAINING 405 26-Nov-19 182390825005 Megha Menon MRW304P 25 239 MP Pharmacology SPECIFY DISORDER OR TANNINS AGAINST EXPERIMENTALLY INDUCED PEPTIC MR. MITTAL DALAL 239 DISEASE) ULCER IN RATS G.I. TRACT ( PLEASE EFFECT OF POLYHERBAL FORMULATION, ACIDEZ, AGAINST 406 26-Nov-19 182390825006 MULLA KAYNAT MUSTAQ MRW304P 25 239 MP Pharmacology SPECIFY DISORDER OR DR. ANKIT MERAI 239 EXPERIMENTALLY INDUCED GASTRIC ULCER IN RATS DISEASE) METABOLIC DISORDER ( EFFECT OF SOYBEAN EXTRACT AND CISSUS 407 26-Nov-19 182390825008 TAILOR SHIVANGI ISHWARBHAI MRW304P 25 239 MP Pharmacology PLEASE SPECIFY QUADRANGULARIS AQUEOUS EXTRACT IN MR. MITTAL DALAL 239 DISORDER) OVARIECTOMIZED RAT MODEL ASSESSMENT OF QUALITY OF PRESCRIPTION AT ICUS IN A 408 26-Nov-19 182440825001 Makwana Payalben Dhirubhai MRW304P 25 244 MP Pharmacology CLINICAL STUDY DR. SAMIR K. SHAH 244 TERTIARY CARE TEACHING HOSPITAL

Page 23 ANALGESIC AND EVALUATION OF ANALGESIC AND ANTI-INFLAMMATORY 409 26-Nov-19 182680825001 CHAUDHARI FALGUNIKUMARI SATISHBHAI MRW304P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY) ANTI- ACTIVITIES OF MANILKARA HEXANDRA (ROXB.) IN WISTAR DR. VIJAY B. LAMBOLE 268 INFLAMMATORY RATS EVALUATION OF ANTIUROLITHIATIC POTENTIAL OF 410 26-Nov-19 182680825002 PATEL CHARMIBEN JAYANTIBHAI MRW304P 25 268 MP Pharmacology RENAL DISORDERS DR. VIJAY B. LAMBOLE 268 MANILKARA HEXANDRA (ROXB.) IN WISTAR RATS EVALUATION OF ANTI-ARTHRITIC POTENTIAL OF ABIES 411 26-Nov-19 182680825003 PRAJAPATI ANKITKUMAR BHARATBHAI MRW304P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY) JOINTS WEBBIANA LINDI. ON EXPERIMENTALLY INDUCED MR. VIPULKUMAR GAJERA 268 ARTHRITIS MODEL IN RATS PHARMACY PRACTICE & TO STUDY THE BENEFICIARY EFFECT OF METFORMIN + Clinical 412 26-Nov-19 182820829004 CHAUDHARI LOKITABEN ANILKUMAR MRW304P 29 282 MP CLINICAL STUDY SITAGLIPTIN COMBINATION VS METFORMIN ALONE IN DR. HETAL D. SOLANKI 282 Pharmacy (DIABETES) TYPE 2 DIABETIC PATIENTS. TO ESTABLISH BIOEQUIVALENCE OF URSODEOXYCHOLIC Clinical 413 26-Nov-19 182820829006 RATHOD TARUN JETHABHAI MRW304P 29 282 MP BABE STUDY ACID CAPSULE IN HEALTHY, ADULT, MALE HUMAN DR. JIGNESH SHAH 282 Pharmacy SUBJECTS UNDER FASTING CONDITION TO ESTABLISH BIOEQUIVALENCE OF GLIPIZIDE EXTENDED Clinical 414 26-Nov-19 182820829007 SHUKLA BHARGAV DINESHCHANDRA MRW304P 29 282 MP BABE STUDY RELEASE TABLET IN HEALTHY, ADULT, MALE HUMAN DR. JIGNESH SHAH 282 Pharmacy SUBJECTS UNDER FED CONDITION TO ESTABLISH BIOEQUIVALENCE OF SODIUM VALPROATE Clinical 415 26-Nov-19 182820829005 KARAN KALPESH BAJANIYA MRW304P 29 282 MP BABE STUDY ORAL SOLUTION IN HEALTHY, ADULT, MALE HUMAN DR. HETAL D. SOLANKI 282 Pharmacy SUBJECTS UNDER FASTING CONDITION A STUDY ON CLINICAL PATTERN OF ADVERSE DRUG Clinical PHARMACOVIGILA REACTIONS TO THE DRUGS USED FOR HYPERTENSION AND 416 26-Nov-19 182820829008 VANDANA AMIT SHARMA MRW304P 29 282 MP OTHER (KINDLY SPECIFY) DR. JIGNESH G. SHAH 282 Pharmacy NCE ASSESMENT OF MEDICATION KNOWLEDGE IN SUCH PATIENTS. TO COMPARE THE PRESCRIBED ANTIHYPERTENSIVE Clinical 417 26-Nov-19 182820829001 KAZI ANJUMARA ZAKIRMIYA MRW304P 29 282 MP CLINICAL STUDY (CVS) MEDICATION USE AND BLOOD PRESSURE CONTROL IN DR. HETAL D. SOLANKI 282 Pharmacy TERTIARY AND PRIMARY HEALTH CARE CENTRE, ANAND. Clinical A COMPARATIVE STUDY OF NIFEDIPINE AND LABETALOL IN 418 26-Nov-19 182820829002 PANDYA SHIVANGI BIPINCHANDRA MRW304P 29 282 MP CLINICAL STUDY (CVS) DR. HETAL D. SOLANKI 282 Pharmacy PREGNANCY INDUCED HYPERTENSION Clinical TO STUDY THE AWARENESS OF SKIN INFECTION AMONG 419 26-Nov-19 182820829003 PATEL PRACHI SHAILESHKUMAR MRW304P 29 282 MP OTHER (KINDLY SPECIFY) SKIN INFECTIONS DR. HETAL D. SOLANKI 282 Pharmacy ADULTS AT TERTIARY CARE CENTRE, ANAND. A COMPARISON OF REGULATORY REQUIREMENTS AS PER Pharmaceutical USFDA & HEALTH CANADA FOR EYE DROPS AND 420 26-Nov-19 182880827002 BARAIYA KOMALBEN BHASKARRAY MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS PREPARATION OF DRAFT ABBREVIATED NEW DRUG DR. KASHYAP THUMMAR 288 Affairs APPLICATION (ANDA) FOR LIFITEGRAST EYE DROPS AS PER USFDA Pharmaceutical TO PROCESS COMPILE & VALIDATE CMC PART OF ANDA 421 26-Nov-19 182880827005 KU SADHVI DHARAMNARAYAN TIWARI MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS MR. PRAVEEN JAIN 288 SUBMISSION IN e-CTD FORMAT Affairs RIVASTIGMINE EXTENDED RELEASE FILM 4.6MG/24 Pharmaceutical HOURS - A GENERIC PRODUCT TO EXELON: PREPARATION 422 26-Nov-19 182880827006 MAURYA PRITIKUMARI RADHESHYAM MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS DR. R.H.PARIKH 288 OF DRAFT ABBREVIATED NEW DRUG APPLICATION (ANDA) Affairs FOR REGISTRATION IN USA Pharmaceutical A STUDY ON REGISTRATION PROCESS OF FEBUXOSTAT 423 26-Nov-19 182880827007 MEHTA HETAL MANISHKUMAR MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS FILM COATED TABLET AS PER CENTRALISED PROCEDURE DR. R.H.PARIKH 288 Affairs OF EUROPEAN MEDICINE AGENCY (EMA)

Pharmaceutical COMPARATIVE GLOBAL REGULATORY APPROACH 424 26-Nov-19 182880827014 ZALA TWINKLE DHANJIBHAI MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS TOWARDS NITROSAMINE IMPURITIES AND TO PREPARE MR.NIRAV CHOKSHI 288 Affairs GUIDANCE DOCUMENT FOR INDIAN REGULATION PREPARATION OF DRAFT ACTD DOSSIER FOR Pharmaceutical COMBINATION OF ARTEMETHER AND LUMEFANTRINE AS 425 26-Nov-19 182880827009 Panchal kinjal pankajbhai MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS A POWDER FOR ORAL SUSPENSION AND A STUDY ON DR. KASHYAP THUMMAR 288 Affairs IMPLEMENTATION OF VARIATION AS PER ASEAN GUIDELINE Pharmaceutical TO PROCESS, COMPILE, FILE TAGGING & VALIDATE 426 26-Nov-19 182880827001 ACHARYA SHARAD HARILAL MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS MR. PRAVEEN JAIN 288 CLINICAL PART OF ANDA SUBMISSION IN e-CTD FORMAT Affairs

Page 24 A STUDY ON REGISTRATION PROCESS AS PER USFDA FOR Pharmaceutical INTRAVENOUS COMBINATION OF CEFTOLOZANE SULFATE 427 26-Nov-19 182880827003 DAVE KEYUR PIYUSHKUMAR MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS DR. R.H.PARIKH 288 & TAZOBACTAM SODIUM - A GENERIC PRODUCT TO Affairs ZERBAXA Pharmaceutical ARFORMOTEROL TARTRATE INHALATION SOLUTION : 428 26-Nov-19 182880827004 KHAMAR VIDHI VINAYBHAI MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS PREPARATION OF DRAFT ABBREVIATED NEW DRUG DR. VISHWAS RANPARIYA 288 Affairs APPLICATION (ANDA) AS PER USFDA Pharmaceutical A STUDY ON ABBREVIATED NEW DRUG APPLICATION 429 26-Nov-19 182880827010 PAREKH ISHANI HITESHKUMAR MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS (ANDA) REGISTRATION PROCESS FOR CANAGLIFLOZIN MS. DIPA MEHTA 288 Affairs TABLET AS PER USFDA. A COMPARATIVE STUDY OF REGULATORY REQUIREMENTS Pharmaceutical IN INDIA & USA FOR MEDICAL DEVICES AND A STUDY OF 430 26-Nov-19 182880827011 PATEL NIDHI HASMUKHBHAI MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS DR. KASHYAP THUMMAR 288 PRODUCT APPROVAL PROCESS FOR IN-VITRO DIAGNOSTICS Affairs (IVDS) AS PER INDIAN REGULATORY SYSTEM Pharmaceutical A STUDY ON BIOSIMILAR PRODUCT REGISTRATION 431 26-Nov-19 182880827012 revati kabariya MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS PROCESS FOR PERTUZUMAB INJECTION THROUGH MS. DIPA MEHTA 288 Affairs CENTRALISED PROCEDURE AS PER EMA A COMPARISON OF REGULATORY REQUIREMENTS AS PER Pharmaceutical USFDA & SOUTH AFRICA FOR POWDER FOR INJECTION 432 26-Nov-19 182880827008 MOURYA MAMTASHANTI SHAMBHUNATH MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS AND PREPARATION OF DRAFT ABBREVIATED NEW DRUG DR.KASHYAP THUMMAR 288 Affairs APPLICATION (ANDA) FOR ENFUVIRTIDE POWDER FOR INJECTION AS PER USFDA Pharmaceutical MODEL DOSSIER FOR WHO PREQUALIFICATION AND 433 26-Nov-19 182880827013 ROHIT KUMAR MRW304P 27 288 MP Regulatory REGULATORY AFFAIRS MR.NIRAV CHOKSHI 288 IMPLEMENTATION OF VARIATION AS PER WHO GUIDELINE Affairs

S/d I/C Contoller of Examination

Page 25